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ABSTRACT 
Functional Electrically Stimulated (FES) ami cycle ergometry is a relatively new 
technique for exercise in individuals with impairments of the upper limbs. The purpose of 
this study was to determine the effects of 12 weeks of FES arm cycle ergometry on upper 
limb function and cardiovascular fitness in individuals with tetraplegia. F!ve subjects 
(4M/1F; mean age 43.8 ± 15.4 years) with a spinal cord injury of the cervical spine (C3-
C7; ASIA B-D) participated in 12 weeks of3 times per week FES arm cycle ergometry 
training. Exercise performance measures (time to fatigue, distance to fatigue, work rate) 
were taken at baseline, 6 weeks, and following 12 weeks of training. Cardiovascular 
measures (MAP, resting HR, average and peak HR during exercise, cardiovascular 
efficiency) and self reported upper limb function (as determined by the CUE, sf-QIF, 
SCI-SET questionnaires) were taken at baseline and following 12 weeks of training. 
Increases were found in time to fatigue (84.4%), distance to fatigue (111.7%), and work 
rate (51.3%). These changes were non-significant. There was a significant decrease in 
MAP (91.1 ± 13.9 vs. 87.7 ± 14.7 mmHg) following 12 weeks ofFES arm cycle 
ergometry. There was no significant change in resting HR or average and peak HR during 
exercise. Cardiovascular efficiency showed an increase following the 12 weeks ofFES 
training (142.9%), which was non-significant. There were no significant changes in the 
measures of upper limb function and spasticity. Overall, FES arm cycle ergometry is an 
effective method of cardiovascular exercise for individuals with tetraplegia, as evidenced 
by a significant decrease in MAP, however it is unclear whether 12 weeks of thrice 
weekly FES arm cycle ergometry may effectively improve upper limb function in all 
individuals with a cervical SCI. 
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I. INTRODUCTION 
A spinal cord injury (SCI) is a traumatic event that results in a decrease in 
function. Changes in muscle begin immediately post injury, and include muscle atrophy 
and muscle fibre type changes. Muscle atrophy, the reduction of cross sectional area 
(CSA) and weakness in the muscles, can cause many health problems and functional 
difficulties. SCI also results in a reduction in fatigue resistance. The reduction in fatigue 
resistance can have a functional effect on individuals with a SCI, as it may limit their 
ability to perform activities of daily living (ADL) and live independently. Individuals 
with a SCI may also experience muscle spasticity. Spasticity can have both detrimental 
and beneficial effects on function. 
Functional limitations are a lack of ability to perform an action within the range 
considered normal that results from impairment (Marino, Shea & Stineman, 1998). The 
impairment of hand and arm function is one of the consequences of cervical SCI. 
Generally, individuals with tetraplegia may experience difficulties with the actions of 
reaching, grasping, and pulling. This may cause functional limitations with activities of 
daily living. In a study conducted by Anderson (2004), 681 individuals with SCI were 
surveyed and the results showed that with regards to quality of life, the return of arm and 
hand function was the highest therapeutic priority to individuals with tetraplegia. 
Recovery of even partial hand and arm function could potentially have a great impact on 
independence. Anderson (2004) also found that 96.5% of individuals with a SCI 
considered exercise to be important for functional recovery, however, only 56.9% had 
access to exercise, and only 12.2% had access to a trained therapist. These findings 
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demonstrate a need for therapies that will both improve hand and arm function, and 
exercise techniques that will improve function. 
Exercise rehabilitation has been shown to be effective in increasing function and 
health after spinal cord injury. Arm ergometry has been shown to result in physical and 
psychological gains. However, not all individuals with SCI have sufficient upper limb 
function to benefit from manual arm ergometry. Functional Electrical Stimulation (FES) 
is a therapeutic intervention for individuals with spinal cord injuries. FES uses surface 
electrodes to activate paralyzed or paretic muscles, and evidence shows that with regular 
use partial recovery of voluntary muscle control can result (Thrasher, Flett & Popovic, 
2006). Recently, FES arm cycle ergometry has become available. FES arm cycle 
ergometry involves electrical stimulation of the biceps and triceps in a sequential cycling 
pattern, and the stimulation of the rotator cuff muscles to provide stabilization of the 
upper limb. The arm cranks that are grasped by the participants are connected to a motor 
that can either assist as the muscles fatigue or add resistance to create greater 
cardiovascular challenge. FES arm cycle ergometry can be beneficial to individuals with 
no arm function or to individuals with some arm function who may benefit from the extra 
stimulation. A recent study found that 12 weeks of3 times per week progressive FES arm 
cycle ergometry resulted in an increase in peak power output in individuals with a C6 
spinal cord injury (Coupaud, Gollee, Hunt, Fraser, Allan & McLean, 2008). Coupaud et 
al. (2008) also looked at peak oxygen uptake (l/min) and found that training effects were 
different for each individual, indicating the variability of exercise responses between 
individuals, which may be related to the completeness of the injury. 
2 
The benefits ofFES arm cycle ergometry are yet to be determined,however it 
may serve in two capacities; I) fill a void regarding exercise rehabilitation options, 2) 
may offer similar adaptations as FES lower extremity cycling, such as increasing muscle 
function, improving cardiovascular endurance, and reducing spasticity, but in the upper 
" 
extremities. The purpose of this study is to investigate the effects of twelve weeks of 
" 
FES arm cycle ergometry at a frequency of 3x1week on upper limb function in 
individuals with chronic (~ I year post-injury) tetraplegia. 
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II. REVIEW OF LITERATURE 
2.1.0 Background 
2.1.1 Epidemiology of Spinal Cord Injury 
A spinal cord injury (SCI) is a traumatic event that results in a decrease in 
function. Approximately 40,000 Canadians are affected by a SCI, with 1,200 new cases 
:, 
occurring each year (Tuszynski, Steeves, Fawcett, Lammertse, Kalichman, Rask, et aI., 
2007). The life expectancy of individuals with a SCI is increasing. The median survival 
time for individuals who sustained an injury between the ages of 25-34 years is predicted 
to be 38 years post injury, with 43% surviving at least 40 years post injury (McColl, 
Walker, Stirling, Wilkins & Corey, 1997). The ratio of males to females with a SCI is 
3.8:1 (McColl et aI., 1997). Sekhon and Fehlings (2001) stated that approximately 40% 
of individuals with a SCI have an injury of the cervical spine. 
2.1.2 Classification of Spinal Cord Injury 
There are two general ways to classify a spinal cord injury, by its neurological 
level, and by its severity. The neurological level refers to the most caudal segment of the 
spinal cord with normal function. Individuals with injuries of the cervical spinal cord are 
referred to as having tetraplegia because they have upper and lower extremity 
impairment, as well as impairment of the trunk and pelvic muscles. Individuals with 
injuries of the thoracic spinal cord and below are referred to as having paraplegia because 
they have impairment of the lower extremities and pelvic muscles, with possible 
impairment of the trunk. The severity of the injury refers to whether it is complete or 
incomplete. A complete injury will have no motor or sensory function at the S4-S5 level. 
Individuals with a complete injury may have a zone of partial preservation, which refers 
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to dermatomes and myotomes caudal to the neurological level that remain partially 
innervated. This means that an individual with a complete injury may have some sensory 
andlor motor function in a few dermatomes and myotomes below the level of injury, but 
not, by definition, at the S4-S5 level. An incomplete injury will result in partial 
preservation of sensory andlor motor function below the injury level. The;\-merican 
Spinal Injury Association (ASIA) classifies complete injuries as ASIA A, and incomplete 
injuries are classified as ASIA B-E, depending on the amount of function maintained 
below the injury level. Individuals with an ASIA B injury have sensory but not motor 
function preserved below the injury level. ASIA C injuries display preservation of 
sensory and motor function below the injury level with more than half the key muscles 
below the neurological level exhibiting less than anti-gravity strength (i.e. less than 3/5 
on the Medical Research Council (MRC) strength scale). ASIA D injuries display sensory 
and motor function preservation below the injury level with at least half of the key 
muscles below the neurological level exhibiting at least anti-gravity strength (i.e. ::::: 3/5 on 
the MRC strength scale). Individuals with an injury classified as ASIA E will have 
normal sensory and motor function. Thus, the range of function is different for each 
individual, depending on the level and severity of the injury. Roughly one half of 
individuals with a SCI have incomplete injuries and therefore some motor andlor sensory 
function below the level of injury (Sekhon & Fehlings, 2001). 
Upper motor neuron injuries refer to injuries of the spinal cord. Lower motor 
neuron injuries refer to damage to the spinal nerves as they leave the spinal cord. A lower 
motor neuron injury by itself is not a SCI although individuals with SCI at T 1 0 or lower 
will often have some lower motor neuron damage as well. Typically, a lower motor 
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neuron injury refers to damage to the cauda equina, which are the peripheral nerves that 
descend in the vertebral column from the L2 vertebral level and below. Spinal cord injury 
can be acute (within the first 2 years of injury, changes in function still occur) or chronic 
(more than 2 years post injury). Spinal cord injury has many effects and often causes loss 
of muscle function, muscle atrophy, and loss of sensory function, all of wb.ich result from 
damage to the somatic nervous system. However, it is important to note that SCI can 
result in autonomic dysfunction below the injury level as well (Bloemen-Vrencken, de 
Witte, Post & van den Heuval, 2007). 
2.2.0 Muscle Adaptations after Spinal Cord Injury 
Changes in muscle begin immediately post injury, and include both muscle 
atrophy and muscle fibre type changes. 
2.2.1 Muscle Atrophy 
Muscle atrophy, the reduction of cross sectional area (CSA) and weakness in the 
muscles, can cause many health problems and functional difficulties. Skeletal muscle 
atrophy has been attributed to central activation loss and the consequent unloading that 
occurs (Castro, Apple, Staron, Campos & Dudley, 1999; Gordon & Mao, 1994). Muscle 
atrophy occurs rapidly during the first weeks following injury, and then gradually slows. 
Gorgey and Dudley (2007) found that at six weeks post-injury the CSA of the thigh 
skeletal muscle was 33% smaller compared to able bodied controls, and decreased 
slightly but did not change significantly during the following three months. Castro et al. 
(1999) found that at six weeks post injury muscle fibre size was 60% that of able bodied 
controls. Average fibre CSA declined further, decreasing by 22% between six and eleven 
weeks post injury, with a smaller decline of 10% occurring from weeks eleven to twenty-
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four. A significant atrophy of27-56% occurred in type I, type IIa, type IIax, and type IIx 
fibres from six to twenty four weeks post injury, which resulted in a fibre CSA of 
approximately one-third of that of the able bodied population (Castro et aI., 1999). Baldi, 
Jackson, Moraille and Mysiw (1998) found that six months post injury there was a 9.5% 
decrease in total body lean mass, a 21.4% decrease in lower limb lean body mass, and a 
26.8% decrease in gluteal lean body mass. Muscle atrophy is associated with many health 
problems. Muscle is the primary site for glucose storage, so atrophy can result in glucose 
intolerance, insulin resistance, and type II diabetes. Jeon, Weiss, Steadward, Ryan, 
Burnham, Bell, et al. (2002) found that 22% of individuals with SCI have Type II 
diabetes compared to only 6% in the able bodied population, and 62% of individuals with 
tetraplegia have abnormal glucose tolerance. Baldi et al. (1998) associated muscle 
atrophy with the health concerns of pressure sores, fractures, and deep vein thrombosis. 
Upper limb atrophy is related to increased risk of pressure sores because upper extremity 
strength and function is needed in order to shift body weight to relieve pressure. Lower 
limb and gluteal atrophy is related to increased risk of pressure sores because of the 
decreased muscle mass/cushion between the skin and bony prominences. 
2.2.2 Changes in Muscle Fibre Type Distribution 
Spinal cord injury results in a reduction in muscle endurance. Following SCI there 
is a shift in muscle fibre type towards type IIx muscle fibre dominance. This fibre type 
shift is, as of yet, unexplained. Type IIx fibres are fast twitch fatigable fibres which, in 
part, account for the decrease in fatigue resistance. Castro et al. (1999) found that the 
percentage oftype IIa fibres decreased from six to twenty-four weeks post injury, while 
the percentage of type IIax + IIx fibres increased. The percentage of type I fibres did not 
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change. It was also demonstrated that individuals with a SCI showed great~r relative 
fatigue than able bodied individuals during exercise bouts at both six and twenty four 
weeks post injury (Castro et aI., 1999). The relative fatigability within the SCI 
participants remained constant from six to twenty four weeks. This shows that individuals 
with a SCI fatigue faster than able bodied individuals, and this increased f~tigability is 
evident as early as 6 weeks post-injury. It has also been shown that following SCI there is 
a reduction in N a+1K + ATPase, which may contribute to the increased fatigability of the 
paralyzed muscle (Ditor, Hamilton, Tamopolski, Green, Craven, Parise & Hicks, 2004). 
The reduction in fatigue resistance can have a functional effect on individuals with a SCI, 
as it may limit their ability to perform activities of daily living (ADL) and live 
independently. 
2.2.3 Spasticity following Spinal Cord Injury 
Individuals with a SCI may experience muscle spasticity. Spasticity can have both 
detrimental and beneficial results. It is possible that persistent spasticity may preserve the 
expression of type I muscle fibres (Ditor et aI., 2004). Spasticity is an involuntary 
random increase in muscle tone. More specifically, Lance (1980) defined spasticity as a 
motor disorder characterized by a velocity dependent increase in tonic stretch reflexes 
(muscle tone) with exaggerated tendon jerks, resulting from hyperexcitability of the 
stretch reflex. Spasticity occurs in individuals with an upper motor neuron injury. 
Individuals with a lower motor neuron injury experience flaccid paralysis, with no 
spasticity, because there is no neurological connection to the spinal cord. Adams and 
Hicks (2005) stated that 65-78% of individuals with chronic SCI experience symptoms of 
spasticity. Bloemen-Vrencken et ai. (2007) surveyed 410 individuals with SCI and found 
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that 57.1 % had experienced spasms during the prior twelve month period. ASIA 
classification and level of injury are predictors for the development of spasticity. Skold, 
Levi, and Seiger (1999) found that 93% of individuals with tetraplegia ASIA A reported 
spasticity, while 78% of individuals with tetraplegia ASIA B-D reported spasticity. 
Spasticity has the potential to negatively affect quality of life in iridividuals with 
SCI. Adams and Hicks (2005) state that spasticity may restrict activities of daily living, 
inhibit walking and self care, cause pain and fatigue, disturb sleep, compromise safety, 
contribute to the development of contractures, pressure ulcers, ~d infections, contribute 
to negative self image, complicate the role of the caretaker, and impede rehabilitation 
efforts. Skold et al. (1999) found that 20% of individuals with SCI found spasticity to 
restrict ADL's, and 4% found spasticity to cause pain. Spasticity may also have some 
beneficial effects, including facilitation of some ADL' s and transfers, increases in muscle 
strength and CSA, and an increase in venous return (Adams & Hicks, 2005). 
2.2.4 Contractures following Spinal Cord Injury 
Joint contractures are common following SCI, and are characterized by a 
limitation in the passive range of motion (ROM) of the affected joints. Contractures 
following immobilization are the result of a chronic lack of stretch across a joint, and in 
conditions of spasticity, muscle imbalances contribute to contracture development 
(Moriyama, Yoshimura, Sunahori & Tobimatsu, 2006). Harvey and Herbert (2002), state 
that contractures are due to a loss of extensibility in the soft tissues spanning joints. 
Dalyan, Sherman & Cardenas (1998) found that of 482 individuals with SCI, 44 (9%) 
developed contractures. Individuals with tetraplegia display a significantly increased 
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incidence of contractures than individuals with paraplegia, with 13.3% all(~ 5.5% 
respectively developing contractures. In individuals with tetraplegia, the shoulder joint 
was found to be the most affected site for contractures, with 48.7% of individuals with 
contractures developing them in the shoulders (Dalyan et aI., 1998). Contractures can 
limit the functional use of limbs, and cause a loss of independence. Contra,ctures may 
delay rehabilitation, and interfere with dressing, transferring, and nursing care (Dalyan et 
aI., 1998). Grover, Gellman and Waters (1996) found that individuals with tetraplegia at 
the C6 level who developed a flexion contracture at the elbow of 25 degrees or more 
experienced a loss of functional level and independence with regard to transfer skills and 
bed mobility. 
2.3.0 Functional Limitationsfollowing Spinal Cord Injury 
Functional limitations are a lack of ability to perform an action within the range 
considered normal that results from impairment (Marino, Shea & Stineman, 1998). The 
impairment of hand and arm function is one of the consequences of cervical SCI. Each 
spinal cord segment is associated with the control of a key muscle: C5 innervates the 
biceps and brachialis, C6 innervates the extensor carpi radialis and brevis, C7 innervates 
the triceps, and C8 innervates the flexor digitorum profundus. However, muscles receive 
innervation from more than one segment, so the strength of a given muscle is a reflection 
of the functioning of two or more cord segments. Durfee (1999) stated that those with 
higher level injuries tend to have difficulty positioning their hand in the work space and 
thus cannot reach or manipulate an object they wish to grasp. Memberg, Crago, and Keith 
(2003) stated that individuals with an injury at the C5-C6 level typically had some 
voluntary function of the elbow flexor muscles, but had no function of the triceps, 
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preventing elbow extension against gravity. A lack of voluntary elbow extension limits 
the ability to reach overhead or push away objects, causing a reduction in the functional 
workspace. Generally, individuals with tetraplegia may experience difficulties with the 
actions of reaching, grasping, and pulling. This may cause functional limitations with 
ADL's, particularly with wheelchair use, catheterization, and transfers. 
Limitations in physical activities and problems with work/daily activities as a 
result of physical health were found to have a significant effect on quality of life 
(Westgren & Levi, 1998). Hammell (2007) found that quality o~ life was diminished by 
functional problems related to the impaired body, including pain, fatigue, and spasticity. 
Anderson (2004) found that with regards to quality of life, the return of arm and hand 
function was the highest therapeutic priority to individuals with tetraplegia. A survey was 
distributed to the SCI community, which asked participants (681) to rank seven functions 
in order of importance to quality of life. Hand and arm function was stated as most 
important by 48.7% of individuals with tetraplegia, followed by sexual function (13%), 
trunk stability (11.5%), bladderlbowel function/autonomic dysreflexia control (8.9%), 
walking movement (7.8%), normal sensation (6.1 %), and relief of chronic pain (4%). 
Recovery of even partial hand and arm function could potentially have a great impact on 
independence. Anderson (2004) also found that that majority of individuals with a SCI 
regard exercise as an important aspect of functional recovery. 96.5% of individuals with a 
SCI considered exercise to be important for functional recovery, however, only 56.9% 
had access to exercise, and only 12.2% had access to a trained therapist. This 
demonstrates a need for therapies that will both improve hand and arm function, and 
exercise techniques that will improve function. 
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2.4.0 Exercise Rehabilitation/or Individuals with Spinal Cord Injury 
Exercise rehabilitation has been shown to be effective in increasing function and 
health after spinal cord injury. However, exercise options are limited in this population. 
Available exercise therapies either target the lower extremities (body weight supported " 
treadmill training, functional electrically stimulated leg cycling), or targerthe upper 
extremities but require a substantial amount of hand and arm strength and function 
(wheelchair propulsion, arm ergometry). Body weight supported treadmill training 
(BWSTT) is an intervention that allows individuals with a SCI to walk supported on a 
treadmill while therapists aid the lower limbs to produce a walking motion. Giangregorio, 
Hicks, Webber, Phillips, Craven, Bugaresti, et al. (2005) found that BWSTT partially 
reversed muscle atrophy following acute (2-6 months post injury) SCI. Following 48 
sessions of BWSTT muscle CSA was increased from 60% to 72% in the thigh and 65% 
to 79% in the calf compared to able bodied controls. However, the upper limbs are left 
untrained. Arm ergometry has been shown to result in physical and psychological gains. 
Hicks, Martin, Latimer, Craven, Bugaresti, and McCartney (2003) found that following 
long-term twice-weekly arm ergometry there was a significant increase in submaximal 
arm ergometry power output and upper body muscle strength, and higher levels of 
satisfaction with physical function, perceived health, and overall quality of life. However, 
upper body therapies such as wheelchair propulsion and arm ergometry involve a specific 
muscle mass, and therefore may be limited by pain and overuse syndromes (Davoodi, 
Andrews & Wheeler, 2002), and may not be feasible for individuals with upper limb 
impairments. 
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2.5.0 Functional Electrical Stimulation 
Functional Electrical Stimulation (FES) is a therapeutic intervention for 
individuals with spinal cord injuries. The purpose of FES is to activate muscles that have 
lost function due to an inhibition of the normal pathways of motor control signals from 
motor areas ofthe brain through the upper and lower motor neurons to the,muscle. When 
the lower motor neurons are intact, muscle force can be generated with electrical 
stimulation of the lower motor neurons (Durfee, 1999). Electrical pulses applied to motor 
nerves create action potentials that propagate along the axons towards the target muscle 
to cause muscle contraction. To cause continuous muscle contraction the FES system 
must induce at least twenty action potentials per second, otherwise the muscle would 
generate twitch, but not a continuous muscle contraction (Popovic, Curt, Keller & Dietz, 
2001). FES uses surface electrodes to activate paralyzed or paretic muscles, and evidence 
shows that with regular use partial recovery of voluntary muscle control can result 
(Thrasher, Flett, & Popovic, 2006). FES produces complex movements that benefit whole 
body systems. The main indication for using FES is a deficiency of muscle function 
(Vitenzon, Mironov & Petrushanskaya, 2004). Vitenzon et al. (2004) state the three main 
tasks ofFES: 1) improving the function of weak muscles, 2) correction ofimpropedy 
performed movements, and 3) acquisition of a movement habit approximating the 
normal. Generally, an FES system that restores motion consists of electrodes, a 
stimulator, a computerized control unit, and sensors (Durfee, 1999). FES lower extremity 
cycling is a method of facilitating exercise. Muscles are stimulated in a sequential pattern 
to produce a cycling motion. It has been demonstrated that FES lower extremity cycling 
has several potential benefits. 
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2.5.1 Effect of Functional Electrical Stimulation on Muscle Mass 
FES lower extremity cycling has been shown 'to prevent loss of lean body mass in 
individuals with a SCI. Specifically, Baldi et al. (1998) found that FES lower extremity 
cycling against progressive resistance prevented a loss and caused moderate increases in 
lean body mass in individuals with acute SCI « 1 year post-injury). Loss~s in lower limb 
lean body mass and gluteal lean body mass were prevented following both three and six 
months of training, and losses in total body lean body mass was prevented following 6 
months of training. FES lower extremity cycling also significantly increased lower limb 
lean body mass and gluteal lean body mass following six months of training (Baldi et aI., 
1998). Chilibeck, Jeon, Weiss, Bell, and Burnham (1999) found that eight weeks ofFES 
lower extremity cycling resulted in a 23% increase in mean fibre area. FES training 
against no resistance failed to result in changes in muscle fibre area, indicating that 
training may have to involve work against resistance in order to induce changes in fibre 
size. Muscle fibre composition was found to be predominantly type II both pre and post 
training (Chilibeck et aI., 1999). Skold, Lonn, Harms-Ringdahl, Hultling, Levi, Nash, et 
aI. (2002) found that leg muscle volume increased 10% as a result of six months of FES 
lower extremity cycling in motor complete individuals with tetraplegia. 
2.5.2 Effect of Functional Electrical Stimulation on Fatigue Resistance 
FES lower extremity cycling has also been shown to improve fatigue resistance in 
individuals with a SCI. Following six weeks ofFES lower extremity cycling Gerrits, de 
Haan, Sargeant, Dallmeijer, and Hopman (2000) found that fatigue resistance improved, 
as indicated by higher forces maintained when assessed in response to 2 minutes of 
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repetitive electrical stimulation of the quadriceps. The maximal rate of force was found to 
be unaffected, and speed of relaxation was found to be increased. 
2.5.3 Effect of Functional Electrical Stimulation on Cardiovascular Endurance 
Cardiovascular endurance has been shown to be increased as a result of FES 
lower extremity cycling. Heesterbeek, Berkelmans, Thijssen & van Kuppevelt (2005) 
found that following 4 weeks ofFES hybrid cycling V02 peak increased 9.3%. FES 
hybrid exercise refers to FES exercise of the lower extremities paired with voluntary 
upper extremity training, such as arm ergometry. It was also demonstrated that FES 
hybrid cycling showed results faster than FES lower extremity cycling alone. Chilibeck et 
al. (1999) found that 8 weeks ofFES lower extremity cycle training resulted in an 
increase in mean work rate during exercise from 0 watts to 5.1 ± 2.4 watts. The average 
total work output increased from OkJ to 9.2 ± 4.4kJ. The duration that subjects were able 
to pedal continuously without assistance increased from 4.3 ± 0.7 minutes to 21.2 ± 5.6 
minutes. Donaldson, Perkins, Fitzwater, Wood, and Middleton (2000) showed that 
following 16 months of FES lower extremity cycling the distance to fatigue increased 
from 1.2km to 12 km. Donaldson et al. (2000) also found that a recovery of voluntary 
function without stimulation occurred following FES lower extremity cycling in an 
individual with a chronic incomplete Tll112 injury, in the form of an increased ability to 
walk short distances and pick up objects off the floor more easily. 
2.5.4 Effect of Functional Electrical Stimulation on Spasticity 
FES lower extremity cycling may also have an effect on spasticity. Adams and 
Hicks (2005) stated that FES lower extremity cycling may cause a change in the 
mechanical properties of the spastic joint by strengthening the antagonists of the spastic 
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muscle, or by decreasing the hyperactivity of spastic muscles through reciprocal 
inhibition. However, Skold et al. (2002) found no effect of training on deconditioning of 
spasticity following six months of training. 
2.6.0 Functional Electrically Stimulated Training of the Upper Extremities • 
FES training of the upper extremities has thus far been mainly appried to grasping 
function as opposed to exercise function. Durfee (1999) stated that the focus ofFES 
systems for the upper extremity has been on restoring hand grasp. Restoration of even a 
basic grasp can have a significant positive impact on function at;Id independence 
throughout the day. Recently, FES arm cycle ergometry has become available. FES arm 
cycle ergometry involves electrical stimulation of the biceps and triceps in a sequential 
cycling pattern, and the stimulation of the rotator cuff muscles to provide stabilization of 
the upper limb. The arm cranks that are grasped by the participants are connected to a 
motor that can either assist as the muscles fatigue or add resistance to create greater 
cardiovascular challenge. FES arm cycle ergometry can be beneficial to individuals with 
no arm function or to individuals with some arm function who may benefit from the extra 
stimulation. A recent pilot study looked at the effect of 12 weeks of thrice weekly 
progressive FES arm cycle exercise on upper limb strength and cardiopulmonary function 
in individuals with C6 tetraplegia (Coupaud, Gollee, Hunt, Fraser, Allan & McLean, 
2008). Coupaud et al. (2008) found that FES arm cycle ergometry resulted in an increase 
in peak power output for both participants in the study, and found that only one 
participant had an increase in peak oxygen uptake, while the other participant had no 
change. Coupaud et al. (2008) state that the different training effects for each individual 
indicates the variability of exercise responses between individuals, which may be related 
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to the completeness of the injury. The benefits ofFES arm cycle ergometry are yet to be 
determined, however it may serve in two capacities; i) fill a void regarding exercise 
rehabilitation options, 2) may offer similar adaptations as FES cycling, such as increasing 
muscle function, improving cardiovascular endurance, and reducing spasticity, but in the 
upper extremities. 
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III. PURPOSE AND HYPOTHESIS 
3.1.0 Statement a/Purpose 
The purpose of this study is to investigate the effects of twelve weeks of FES arm cycling 
at a frequency of 3xJweek on upper limb function in individuals with chronic (2: 1 year " 
post-injury) tetraplegia. 
3.2.0 Hypothesis 
In terms of performance it was hypothesized that 12 weeks ofFES upper extremity 
cycling would increase performance ability in the areas of time and distance cycled as 
well as kcallhr expended on an exercise to fatigue cycling test. It was expected that 
resistance and calories burned would increase throughout the training sessions. In terms 
of cardiovascular function it was predicted that resting heart rate and blood pressure 
would decrease and that average and peak heart rate at any given workload would 
decrease following the twelve week training protocol. In terms of upper limb function, it 
was hypothesized that upper extremity function and independence levels were expected 
to increase following the FES training. The CUE scores of function were expected to 
move towards 7 (not at all limited), and the sf-QIF scores were expected to move towards 
a score of 4 (independent). Spasticity following twelve weeks of FES upper extremity 
cycling was expected to become less problematic. SCI-SET scores that started in the 
negative were expected to move towards 0 (no effect), and scores that started in the 
positive were expected not to change. Overall, after 12 weeks ofFES upper extremity 
cycling participants were expected to demonstrate improvements in function and 
independence, as well as endurance. 
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IV. METHODOLOGY 
4.1.0 Subjects 
Table 1. Subject details. Age and Time Since Injury (TSI) are as at the start of 
participation. 
Subject Neurological ASIA TSI Age Sex 
Level Grade {~ears) (years) 
1 C4 B 7 26 M 
2 C5 D 20 46 M 
3 C5 C 11 30 M 
4 C3 D 30 58 F 
5 C3 B 2 59 M ~ 
Five subjects (mean age 43.8 ± 15.4 years) with chronic SCI were recruited to 
participate in this study. Participants had a SCI of the cervical level (C3-C7) resulting in 
either complete or incomplete tetraplegia (ASIA A-D). The details for the subjects are 
given in Table 1. All individuals were medically stable and were at least one year post 
injury. Participants were recruited from the patient list of Dr. Richard McMillan ofthe 
Hotel Dieu Shaver Hospital in St. Catharines, Ontario, and from the MacWheeler 
exercise program at McMaster University. All participants received medical clearance by 
either Dr. Richard McMillan, or their family physician, before beginning the study, and 
had no FES training or other exercise training in the three months prior to the study. 
Individuals were excluded from the study if they had documented cardiovascular disease, 
a tracheostomy, uncontrolled autonomic dysreflexia, or any other medical condition 
contraindicating exercise. Participants were not asked to discontinue any of their 
medications during the testing or training sessions, as no medications associated with SCI 
are contraindicated for FES. Informed consent was obtained following medical clearance. 
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Participants could decline participation in the study or withdraw from the study at any 
time without penalty. 
4.2.0 Exercise training protocol 
The training protocol included a total of twelve weeks of FES arm cycling, at a 
frequency of three sessions per week, with 30-45 minutes of active exercise per session. 
A previous study has shown this volume of exercise to increase fatigue resistance in 
individuals with quadriplegia following 6 weeks ofFES lower extremity cycling (Gerrits 
et aI., 2000). There was 48 hours of rest between exercise sessions whenever possible. 
FES arm cycle ergometry was completed on the RT300 cycle ergometer (Restorative 
Therapies Inc., Baltimore, MD.). The RT300 consists of a six-channel stimulator. The 
stimulation pulses were biphasic and charge-balanced. Surface electrodes (PALS 
Platinum) were placed on the biceps, triceps, deltoids, and supraspinatus muscles. The 
stimulation pulsewidth was set at 250)ls, and the stimulation frequency was set at 50Hz 
for the biceps and triceps electrodes and 25Hz for the shoulder electrodes. The 
stimulation current amplitude was variable from OrnA to 140 rnA, although this study 
used a maximum amplitude of 50mA. Each exercise session began with a two minute 
passive warm up, followed by thirty minutes of active FES arm cycling, and was 
completed with a two minute passive cool down. Motor support assisted the active 
therapy when necessary, up to ten minutes in duration. 
The exercise was progressed as individually tolerated by increasing the duration 
of exercise, followed by increasing the resistance of the arm cranks. Arm crank resistance 
was increased upon the completion of two exercise sessions of at least 30 minutes 
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duration without reaching fatigue. Fatigue was reached when the muscles ",ere no longer 
able to produce enough force to maintain a set level of pedalling cadence. Fatigue was set 
at a pedalling rate ofless than 35rpm, and a maximum of five runs per session was 
allotted to complete a 30-45 minute exercise session (Baldi et aI., 1998; Gerrits et aI., 
2000; Skold et aI., 2002). Following fatigue a five minute rest session was ,completed, 
and then exercise began again. A pulse oximeter was applied to the right ear during 
exercise sessions to monitor oxygen saturation and heart rate during exercise. Participants 
had to maintain an exercise adherence of at least 75% for their data to be included in the 
analysis, meaning they were required to complete the first 18 exercise sessions within 8 
weeks or they were excluded from the study, and they were required to complete at least 
27 sessions within 12 weeks or their data would not be included in the final results. When 
sessions were missed, efforts were made to reschedule the training session to maintain 
three exercise sessions per week. 
4.3.0 Outcome Measures 
Outcome measures were both performance based and functionally based. 
Outcome measures pertaining to exercise performance were taken at baseline, six weeks, 
and upon completion of twelve weeks of FES arm cycle training. Outcome measures 
pertaining to cardiovascular function and upper limb function were taken at baseline and 
upon completion of twelve weeks of FES arm cycle training. Pre-testing took place 24-72 
hours prior to the first training session. The post-testing session occurred 48-72 hours 
after the final training session. Post-testing occurred 48-72 hours after the final training 
session in order to ensure that the results were due to chronic exercise training effects as 
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opposed to acute exercise effects. Exercise performance and cardiovascular measures 
were collected using the RT300 system and pulse oximeter. 
4.3.1 Exercise Performance Measures 
Performance based measures were collected via an exercise to fatigue test. This 
test was conducted at baseline, six weeks, and following the twelve weeks of training, 
and the resistance used for each individual was held constant for each test. These 
measures of performance included time to fatigue, distance cycled to fatigue, and work 
rate (kcallhr expended). Performance was also measured by tracking the training sessions 
for changes in resistance, time to fatigue, distance to fatigue, kcaVhr expended, and total 
work (as measured by total calories burned). 
4.3.2 Cardiovascular Performance Measures 
Cardiovascular measures were conducted at baseline and following twelve weeks 
of FES arm ergometry exercise. Cardiovascular measures included resting heart rate, 
resting blood pressure, average heart rate and peak heart rate during exercise to fatigue 
tests, and cardiovascular efficiency ([work load] / [heart rate]) for both exercise to fatigue 
tests and during training sessions. Resting heart rate and blood pressure were taken prior 
to the exercise to fatigue test using a digital sphygmomanometer. The RT300 system 
collected average and peak heart rate during the exercise to fatigue tests. Average heart 
rate was measured as the mean heart rate throughout the exercise bout. Peak heart rate 
was measured as the highest heart rate achieved during the exercise bout. Cardiovascular 
efficiency was calculated using the work rate and average heart rate data collected by the 
RT300 system. 
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4.3.3 Upper Limb Function Measures 
Functional measures included upper extremitY function, the ability to use the 
upper limbs to complete activities of daily living, and resting self-reported muscle 
spasticity. Upper extremity function was measured with the Capabilities of Upper 
Extremity Questionnaire (CUE; Marino et aI., 1998). The CUE rates 32 it~ms on how 
well individuals with SCI can perform movements with their arms and hands. The left 
and right upper extremities are considered separately on a seven point scale, with 1 = 
totally limited, and 7 = not at all limited. The CUE has a high test-retest reliability 
(ICC=.94) (Marino et aI., 1998). The ability of the upper limbs to complete activities of 
daily living was measured with a short form of the Quadriplegia Index of Function (sf-
QIF; Marino & Goin, 1999). The sf-QIF rates six items on how independent individuals 
with tetraplegia are when performing activities of daily living that are dependent on upper 
limb function. Items are rated on a five-point scale, with 0 = dependent and 4 = 
independent. The interrater reliability of the QIF is good (Pearson's r=0.68 to 0.98), and 
the sf-QIF score and the QIF score are correlated highly (Spearman correlation = 0.978) 
(van Tuijl, Janssen-Potten, & Seelen, 2002). Self-reported muscle spasticity was 
determined by the Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET; Adams, 
Martin-Ginis & Hicks, 2007). The SCI-SET is a seven day recall self-report questionnaire 
that rates how problematic or helpful the participant finds spasticity in terms of 
completing activities of daily living. The SCI-SET rates 35 items using a seven point 
scale, with - 3 = extremely problematic, 0 = no effect, and +3 = extremely helpful. 
Internal consistency (0.=.90) and test-retest reliability (ICC=.91) are adequate for this 
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measure, and the SCI-SET showed strong correlations with measures of self-report 
spasticity severity and self-assessed spasticity impact (Adams et aI., 2007). 
4.4.0 Data Analysis 
All of the statistics were calculated using Excel and Statistica. Exercise 
performance measures were compared within the group using one-way repeated measures 
ANOV A. Tukey post hoc analysis was used to compare specific differences between 
means when necessary. Differences in cardiovascular performance measures and upper 
limb function measures were determined using student's t-tests.'Statistical significance 
was set at p::; 0.05. 
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V.RESULTS 
Participants completed a total duration of 12 weeks ofFES arm cycle ergometry 
training. There was an 85% exercise adherence, with participants completing 28-34 of the 
36 possible FES arm ergometry training sessions. Common problems that hindered 
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attendance were illnesses, transportation on holidays, and difficulty schedvling 
transportation. 
5.1.0 Exercise Performance Results 
5.1.1 Case Study Participant 1 
Participant 1 was a 26 year old male, 7 years post C4 ASIA B spinal cord injury. 
Testing Data 
Participant 1 completed the FES arm cycle ergometry tests at a resistance of 
1.00 Nm. Following 12 weeks of training participant 1 had an 11.7% increase in time to 
fatigue, 31.4% increase in distance to fatigue, and 77.2% increase in kcallhr expended. 
Training Data 
Table 2. Changes in the exercise performance of participant 1 during training sessions. 
Session Active Distance Total Work Work Rate Resistance 
Exercise (min) (miles) (kcal) (kcal/hr) (Nm) 
1 29.48 3.1 0.6 1.5 1.00 
18 30.25 3.7 0.59 1.23 1.00 
34 33.25 3.39 0.65 1.22 1.00 
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5.1.2 Case Study Participant 2 
Participant 2 was a 46 year old male, 20 years post C5 ASIA D spinal cord injury. 
Testing Data 
Participant 2 completed the FES arm cycle ergometry tests at a resistance of 
1.00 Nm. Following 12 weeks of training participant 2 had a 10.5% increase in time to 
fatigue, 30.9% increase in distance to fatigue, and 97.9% increase in kcallhr expended. 
Training Data 
Table 3. Changes in the exercise performance of participant 2 dl;lfing training sessions. 
Session 
1 
18 
28 
Active 
Exercise (min) 
30.24 
30.34 
33.29 
5.1.3 Case Study Participant 3 
Distance 
(miles) 
2.95 
3.31 
3.68 
Total Work 
(kcal) 
0.55 
0.84 
0.96 
Work Rate 
(kcal/hr) 
1.25 
1.74 
1.88 
Resistance 
(Nm) 
1.00 
1.00 
1.00 
Participant 3 was a 30 year old male, 11 years post C5 ASIA C spinal cord injury. 
Testing Data 
Participant 3 completed the FES arm cycle ergometry tests at a resistance of 
4.08 Nm. Following 12 weeks of training participant 3 had a 289.6% increase in time to 
fatigue, 336.9% increase in distance to fatigue, and 77.2% increase in kcallhr expended. 
Training Data 
Table 4. Changes in the exercise performance of participant 3 during training sessions. 
Session Active Distance Total Work Work Rate Resistance 
Exercise (min) (miles) (kcal) (kcal/hr) (Nm) 
1 45.00 8.06 5.67 7.56 1.98 
18 36.13 4.79 4.02 8.18 4.08 
28 45.00 7.44 18.28 24.38 7.02 
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5.1.4 Case Study Participant 4 
Participant 4 was a 58 year old female, 30 years post C3-5 ASIA D spinal cord 
Injury. 
Testing Data 
Participant 4 completed the FES arm cycle ergometry tests at a resistance of 
1.00 Nm. Following 12 weeks of training participant 4 had an 87% increase in time to 
fatigue, 78.3% increase in distance to fatigue, and a 5.5% decrease in kcal/hr expended. 
Training Data 
Table 5. Changes in the exercise performance of participant 4 during training sessions. 
Session 
1 
18 
32 
Active 
Exercise (min) 
45.00 
45.00 
38.5 
5.1.5 Case Study Participant 5 
Distance 
(miles) 
6.07 
8.21 
5.13 
Total Work 
(kcal) 
2.2 
18.6 
12.7 
Work Rate 
(kcal/hr) 
5.2 
23.8 
16.3 
Resistance 
(Nm) 
1.00 
6.04 
7.16 
Participant 5 was a 59 year old male, 2 years post C3 ASIA B spinal cord injury. 
Testing Data 
Participant 5 completed the FES arm cycle ergometry tests at a resistance of 
1.00 Nm. Following 12 weeks of training participant 5 had a 0.3% decrease in time to 
fatigue, a 13.3% decrease in distance to fatigue, and no change in work rate. 
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Training Data 
Table 6. Changes in the exercise performance of participant 5 during training sessions. 
Session 
1 
18 
31 
Active 
Exercise (min) 
33.26 
33.24 
33.26 
Distance 
(miles) 
2.5 
2.15 
2.06 
5.1.6 Exercise Performance Group Data 
Total Work 
(kcal) 
0.5 
0.3 
0.3 
Work Rate 
(kcallhr) 
0.9 
0.6 
0.5 
Resistance 
(Nm) 
1.00 
1.00 
1.00 
Analysis of variance demonstrated no significant main effect for any measure of 
exercise performance. Figure 1 demonstrates time to fatigue in seconds at the baseline, 6 
week, and 12 week exercise to fatigue testing sessions. Time to fatigue showed an 
increase of 84.4% following 12 weeks ofFES arm cycle ergometry training (p=0.22). 
This was non-significant. Figure 2 demonstrates changes in distance to fatigue in miles at 
baseline, 6 week, and 12 week exercise to fatigue testing sessions. Distance to fatigue 
showed an increase of 111.7% following 12 weeks ofFES arm cycle ergometry training 
(p=0.28). This was non-significant. Figure 3 demonstrates changes in work rate in kcallhr 
expended at baseline, 6 week, and 12 week exercise to fatigue testing sessions. Work 
rate showed an increase of51.3% following 12 weeks ofFES arm cycle ergometry 
training (p=0.35). This was non-significant. 
5.2.0 Cardiovascular Performance Results 
5.2.1 Case Study Participant 1 
Following 12 weeks of training participant 1 had a 2.9% decrease in mean arterial 
pressure (MAP), and a 6.6% increase in resting HR. Average HR during the exercise to 
fatigue test did not change following 12 weeks of training. However, Peak HR increased 
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from 79bpm to 89bpm, and cardiovascular efficiency increased 76.5% (0.017kcallhr/HR 
to 0.03 kcallhrlHR) following 12 weeks of training. At both training session 1 and session 
34 cardiovascular efficiency reached a highest level of 0.019 kcallhrlHR. 
5.2.2 Case Study Participant 2 
Following 12 weeks of training participant 2 had a 2.1 % decrease in MAP and no 
change in resting HR. Average HR during the exercise to fatigue test decreased from 
63bpm to 61bpm, peak HR decreased from 68bpm to 65bpm, and cardiovascular 
efficiency increased 106.7% (0.015kcallhr/HR to 0.031kcallhr/HR) following the 12 
weeks of training. Throughout the training sessions cardiovascular efficiency changed 
from 0.02kcallhrlHR during session 1, to 0.03kcallhr/HR during session 28. 
5.2.3 Case Study Participant 3 
Following 12 weeks of training there was a 2.1 % decrease in MAP, and a 6.5% 
increase in resting HR. Average HR during the exercise to fatigue test decreased from 
96bpm to 84 bpm, peak HR decreased from 107bpm to 102bpm, and cardiovascular 
efficiency increased 377.3% (0.044kcallhrIHR to 0.21kcallhr/HR) following the 12 
weeks of training. Throughout the training sessions cardiovascular efficiency changed 
from 0.083kcallhrlHR during session 1, to 0.23kcallhrlHR during session 28. 
5.2.4 Case Study Participant 4 
Following 12 weeks of training there was an 8.1 % decrease in MAP, and an 
11.4% increase in resting HR. Average HR during the exercise to fatigue test decreased 
from 84bpm to 80bpm, peak HR decreased from 96bpm to 85bpm, and cardiovascular 
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efficiency decreased 1.6% (0.064kcallhr/HR to 0.063kcallhr/HR) following the 12 weeks 
of training. Throughout the training sessions cardiovascular efficiency changed from 
0.073kcallhr/HR during session 1, to 0.24kcallhrlHR during session 32. 
5.2.5 Case Study Participant 5 
Following 12 weeks of training there was a 5% decrease in MAP, and no change 
in resting HR. Average HR during the exercise to fatigue test increased from 80bpm to 
92bpm, peak HR increased from 89bpm to 97bpm, and cardiovascular efficiency 
increased from Okcallhr/HR to 0.0054kcallhr1HR following the '12 weeks of training. 
Throughout the training sessions cardiovascular efficiency changed from 
0.008kcallhrlHR during session 1 to 0.006kcallhr/HR during session 31. 
5.2.6 Cardiovascular Performance Group Data 
Figure 4 shows the change in resting MAP (mmHg) before and after the 12 week 
training program. There was a significant 3.7% reduction in resting MAP following 
training (p=0.027). Figure 5 shows the changes in resting HR (bpm) at the baseline and at 
the 12 week exercise to fatigue tests. Resting HR increased 4.8%, but this change was not 
statistically significant (p=0.12). Average HR (79.4 ± 12.19 vs. 78.2 ± 11.63bpm; 
p=0.77) and peak HR (87.8 ± 15.06 vs. 87.6 ± 14.28bpm; p=0.96) during the exercise to 
fatigue tests did not significantly change. Figure 6 shows the change in cardiovascular 
efficiency (kcallhrIHR) at baseline and 12 week exercise to fatigue tests. Cardiovascular 
efficiency increased 142.9% following the 12 weeks of training; however this was not a 
statistically significant change (p=0.28). 
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5.3.0 Upper Limb Function Results 
5.3.1 Case Study Participant 1 
Participant 1 showed a 17% increase in the overall CUE scores. When considering 
the subsets of the CUE by muscle group, participant 1 showed an 84.6% increase in 
shoulder function scores, a 7.7% decrease in biceps function scores, and a 4.2% increase 
in triceps function scores. Participant 1 showed a 100.3% increase in the sf-QIF scores, 
and had a 9.9% increase in SCI-SET total scores, with an 8.8% increase in the questions 
relating to arm spasticity. 
5.3.2 Case Study Participant 2 
Participant 2 showed a 15.8% decrease in the overall CUE scores. When 
considering the subsets of the CUE by muscle group, participant 2 showed a 20.7% 
decrease in shoulder function scores, a 38.5% decrease in biceps function scores, and a 
12.5% decrease in triceps function scores. Participant 2 showed a 100% decrease in the 
sf-QIF scores, and had a 3.1 % increase in SCI-SET scores, with a 4.4% increase in the 
questions relating to arm spasticity. 
5.3.3 Case Study Participant 3 
Participant 3 showed a 1.3% increase in the overall CUE scores. When 
considering the subsets of the CUE by muscle group, participant 3 showed an 8.8% 
decrease in shoulder function scores, and no change in biceps or triceps function scores. 
Participant 3 showed a 35.9% increase in the sf-QIF scores, and had a 2.4% decrease in 
SCI-SET scores, with a 1.1 % decrease in the questions relating to arm spasticity. Notable 
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changes in participant 3 included a change from being able to turn supine to side in bed 
with an assistive device, to turning supine to side in bed without an assistive device. 
Participant 3 also changed from requiring supervision to transfer from bed to chair to 
being able to transfer from bed to chair independently without a device. 
5.3.4 Case Study Participant 4 
Participant 4 showed a 35.9% increase in the overall CUE scores. When 
considering the subsets of the CUE by muscle group, participant 4 showed a 42.1 % 
increase in shoulder function scores, a 10% increase in biceps function scores, and an 
18.2% increase in triceps function scores. Participant 4 showed a 4.7% increase in the sf-
QIF scores, and had a 25.2% increase in SCI-SET scores, with a 20.6% increase in the 
questions relating the arm spasticity. Notable changes in participant 4 included a change 
from being able to transfer from bed to chair using an assistive device to transferring 
from bed to chair without an assistive device. 
5.3.5 Case Study Participant 5 
Participant 5 showed a 5.5% decrease in the overall CUE scores. When 
considering the subsets of the CUE by muscle group, participant 5 showed a 14.3% 
decrease in shoulder function scores, a 14.3% decrease in biceps function scores, and a 
12.5% decrease in triceps function scores. Participant 5 showed no change in the sf-QIF 
scores, and had a 1.7% decrease in SCI-SET scores, with a 2.4% decrease in the 
questions relating to arm spasticity. 
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5.3.6 Upper Limb Function Group Data 
No significant changes were found in upper limb function. Figure 7 shows the 
change in the total CUE score at baseline and following the 12 weeks of training. The 
total CUE score increased 6.7% (119.6 ± 49.4 vs. 127.6 ± 54.2; p=0.54) following the 12 
weeks of FES training. When considering the subsets of the CUE by musCle group, 
shoulder function showed an increase of 8.8% (20.4 ± 11.13 vs. 22.2 ± 9.58; p= 0.61; 
Fig.8), biceps function decreased· 1 0.5% (p=0.34; Figure 9), and triceps function 
decreased 3.4% (p=0.59; Figure 10). These changes were non-s~gnificant. Figure 11 
shows the change in QIF total scores at baseline and following the 12 weeks of training. 
The QIF scores showed an increase of 18% (7.8 ± 9.8 vs. 9.2 ± 10.9; p=0.25). This was 
non-significant. For the QIF question pertaining to turning from supine to side in bed 
there was an increase in average score from 1.2 to 1.4 (p=0.37), and for the question 
pertaining to transferring from bed to chair there was an increase in average score from 1 
to 1.6 (p=0.21). Figure 12 shows the change in SCI-SET total scores at baseline and 
following the 12 weeks ofFES training. The SCI-SET scores showed an increase of 5.9% 
(122.6 ± 14.9 vs. 129.8 ± 9.2; p=0.23). This was non-significant. Specifically, there was a 
5.4% increase in questions pertaining to arm spasticity. The SCI-SET scores spasticity as 
having either a negative effect, no effect, or a positive effect on ADL's and quality oflife. 
A desired effect would be for negative scores to move towards having no effect or a 
positive effect, and for positive scores to remain unchanged. With regards to spasticity 
having a negative vs. positive effect, the vast majority of scores started in the negative, 
but only made a non-significant shift towards zero (-0.43 ± 0.48 vs. -0.29 ± 0.26; 
p=0.44), following the 12 weeks ofFES arm cycle ergometry. Dfthe 5 participants, only 
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2 had any pre-test SCI-SET scores indicating that spasticity had a positive effect on their 
functioning. A total of 5 scores (of a possible 175) began with a positive score, and 
following the 12 weeks of FES arm cycle ergometry training these items showed a 
decrease, which was non-significant (1.0 ± 0.0 vs. 0.8 ± 1.3; p=0.75). A shift ofthis kind 
indicates a loss in functional spasticity. Participant 1 gave a positive ratinK to the items 
pertaining to showering, positioning while lying down, and the ability to change positions 
in bed. Following the 12 weeks ofFES training participant 1 showed an increase in 
spasticity's assistance to showering, but showed a decrease to the point of spasticity 
having no effect on his ability to position himself while lying down and change his 
position in bed. Participant 3 gave a positive rating to the items pertaining to transfers and 
therapy/exercise. Following the 12 weeks ofFES training participant 3 showed no change 
in spasticity's assistance to transferring, but showed a decrease to the point of spasticity 
having no effect on his ability to participate in therapy/exercise. 
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VI. DISCUSSION 
The main findings of the present study are a s'ignificant decrease in MAP, and 
increases in exercise performance and upper limb function which were non-significant. 
The small sample size may be responsible for the non-significant results in exercise 
performance and upper limb function. Notable changes include an increas~ in CUE scores 
and QIF scores following the 12 weeks ofFES arm cycle ergometry training, indicating 
an increase in the functional use of the upper limbs. 
6.1.0 Exercise Performance 
The mean time to fatigue showed an increase of 84.4% following the 12 weeks of 
FES arm cycle ergometry training. This was non-significant, but suggests a change in the 
upper limb muscles fatigue resistance. This finding agrees with previous results of FES 
leg cycle ergometry training. For example, Chilibeck et al. (1999) found that 8 weeks of 
FES leg cycle ergometry increased the duration participants were able to pedal, and 
Gerrits et al. (2000) found that fatigue resistance was improved following 6 weeks ofFES 
leg cycle ergometry training, as indicated by maintaining higher forces in response to 
repetitive electrical stimulation. In the present study Participant 3 and participant 4 
showed a greater increase in time to fatigue than other participants, and also increased the 
resistance they were pedalling against. These participants had motor incomplete ASIA 
grades, meaning they had higher functional ability prior to the study, which may have 
meant they needed less assistance from the FES. These participants may have had been 
able to pedal longer before fatiguing because they could pedal without assistance from 
the bike for a portion of the exercise. Participant 2 also had a motor incomplete ASIA 
score, however only increased his time to fatigue slightly, and did not progress from his 
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initial resistance. This could have been because he had a high level of sensation, which 
limited how much stimulation he could receive. Participant I and participant 5 also only 
improved their time to fatigue slightly, which may be attributed to the fact that they were 
graded ASIA B. Individuals with an ASIA score of A or B have the ability to improve 
muscle mass, however they do not have the ability to activate the muscle, p1eaning they 
can only improve involuntary strength. Individuals with an ASIA score of CorD can 
improve both voluntary and involuntary strength. Both participant 1 and participant 5 
needed motor assistance to complete the required bouts of exercise, meaning that the 
stimulation was not enough to assist them in pedaling against resistance. There was 
however no correlation between pre-existing functional ability and the results. 
The mean distance to fatigue showed an increase of 111.7% following the 12 
weeks of FES arm cycle ergometry training. This was non-significant. This agrees with 
the findings of Donaldson et al. (2000), who showed that 16 months of FES leg cycle 
ergometry produced an increase in distance to fatigue pedalled. Participant 3 and 
participant 4 had higher increases in distance pedalled than the other participants. This is 
consistent with the increase these participants had in time to fatigue, and may be 
attributed to the participants' ASIA scores (C&D). Participant 1 and participant 2 also 
experienced an improvement in distance to fatigue following the training protocol, 
however, their relative increase in distance to fatigue was greater than their relative 
increase in time to fatigue, indicating that they were pedalling harder or faster during the 
duration of exercise. Participant 5 had a decrease in distance to fatigue overall. It should 
be noted that participant 5 was receiving physiotherapy until training session 3, which 
then was stopped due to a flu outbreak at the hospital. Distance to fatigue then began to 
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decrease, and stiffness in the upper limbs increased. However, there was ap. increase from 
the 6 week testing to the post testing, indicating that the FES arm cycle ergometry may 
have been causing an improvement. 
The mean work rate (kcallhr) showed an increase of 51.3% following the 12 
weeks of FES arm cycle ergometry training. This was non-significant. This increase in 
work rate agrees with previous arm cycle ergometry studies. Hicks et al. (2003) found 
that following 9 months of exercise training including manual arm ergometry there was a 
significant increase in submaximal arm ergometry power outpu~ of 81 %. Arm ergometry 
without the FES component could produce results similar to FES arm cycle ergometry, 
however individuals with lower levels of upper limb function may not be able to pedal 
the bike unassisted. Coupaud et al. (2008) found that power output (W) increased 
following 12 weeks ofFES arm cycle ergometry, which would indicate an increase in 
work rate. FES leg cycle ergometry also has been found to cause increases in work rate. 
For example, Chilibeck et al. (1999) found an increase in average total work output (kJ) 
from 0 to 9.2 ± 4.4kJ following 8 weeks ofFES leg cycle ergometry. 
6.2.0 Cardiovascular Performance 
The mean resting MAP (mmHg) showed a significant decrease following the 12 
weeks ofFES arm cycle ergometry. This differs from the findings of Hicks et al. (2003), 
which showed no change in systolic or diastolic blood pressure following 9 months of 
exercise training including arm cycle ergometry. The training protocols used in these 
studies differed in that Hicks et al. (2003) included only 2 training sessions per week, and 
included strength training along with 15-30 minutes of sub maximal arm cycle ergometry, 
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while in the current study participants completed 3 sessions per week of at least 30 
minutes of exercise. The higher concentration of exercise bouts in the current study may 
have been necessary for the change in blood pressure. Individuals with a spinal cord 
injury are at an increased risk for cardiovascular disease. Heart disease is the second 
leading cause of death among individuals with a spinal cord injury (Deviv:p, Black, & 
Stover, 1993). The risk of cardiovascular disease is increased by high blood pressure, and 
decreased by lowering blood pressure. FES arm cycle ergometry decreases MAP, thus 
may be effective at reducing the risk of developing cardiovascular disease in individuals 
with tetraplegia. Devivo et al. (1993) suggested that increasing exercise participation 
would have a greater impact on the life expectancy of individuals with a spinal cord 
injury than the general population, due to the effect exercise has on assisting in the 
prevention of heart disease. FES arm cycle ergometry could provide a means of 
cardiovascular exercise for individuals who have limited arm function, and has the 
potential to increase the life expectancy of individuals with tetraplegia due to its effect on 
blood pressure. 
The mean resting HR (bpm) showed an increase following the 12 weeks ofFES 
arm cycle ergometry. This was non-significant. This agrees with the findings of Hicks et 
al. (2003) which found no change in resting HR following 9 months of exercise training. 
Average and peak HR during the exercise to fatigue tests did not significantly change. 
This differs from the findings Hicks et al. (2003), which found a significant increase in 
HR during the 9 month arm cycle testing session. Average and peak HR during the 
exercise to fatigue tests may have remained constant due to the fact that while the heart 
may have been more efficient, the work they were doing was increasing, so no effect was 
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seen. This relates to cardiovascular efficiency. Mean cardiovascular efficiency 
(kcal/hrIHR) showed an increase following the 12 weeks ofFES arm cycle ergometry 
training. This was non-significant. This indicates that participants could perform more 
work at a given HR after the 12 weeks ofFES arm cycle ergometry training than at 
baseline. Hicks et ai. (2003) looked at the relationship between HR and poyver output and 
also found that 9 months of exercise training produced greater cardiovascular efficiency 
(as measured by a significant decline in the HRIW ratio), and also found that individuals 
with tetraplegia experienced a greater decrease in the HR for a given power output than 
individuals with paraplegia. 
6.3.0 Upper Limb Function 
The mean total CUE score showed an increase of6.7% following the 12 weeks of 
FES arm cycle ergometry. This was non-significant. This finding could indicate an 
increase in upper limb strength, which would agree with Hicks et ai. (2003) finding that 
arm cycle ergometry paired with resistance training increased upper body muscle strength 
following 9 months of training. Hicks et ai. (2003) also found that participants had higher 
levels of satisfaction with their physical functioning following the exercise training. 
Donaldson et ai. (2000) found an increase in voluntary muscle function following FES 
leg cycle ergometry, in terms of an increased ability to walk. FES arm cycle ergometry 
may therefore increase voluntary muscle function in the upper limbs, leading to an 
increase in function, as indicated by the large but non-significant increase in CUE scores 
in the present study. There has been evidence that FES leg cycle ergometry causes 
changes in muscle (Skold et aI., 2002; Baldi et aI., 1998; Chilibeck et aI., 1999), however 
these studies did not investigate putative functional changes. The mean shoulder function 
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as indicated by the CUE showed an increase of8.8% following the 12 weeks ofFES arm 
cycle ergometry, while biceps CUE scores showed a decrease of 10.5%, and triceps CUE 
scores showed a decrease of 3.4%. These changes were non-significant. This is an 
unexpected result, as the shoulder stimulation with the RT300 is intended for support of 
the shoulder joint during FES arm cycle ergometry, as opposed to the biceps and triceps 
stimulation which is used for the actual pedalling of the bike against resistance. It was 
hypothesized that limb function would increase, as was indicated by the overall CUE 
score, however it was also expected that biceps and triceps function would show 
relatively more improvement than the deltoids. 
The mean total QIF scores showed an increase of 18% following the 12 weeks of 
FES arm cycle ergometry. This was non-significant. Participant 2 showed a decrease in 
QIF scores, and participant 5 showed no change. As stated before, participant 2 had high 
sensation levels, and could not handle high levels of stimulation, so may not have seen 
changes in muscle strength and function. Participant 5 has a high level ASIA score, 
which could decrease his capacity for improvement. Participant 1 and participant 3 had a 
greater level of improvement than participant 4. Looking at the initial scores for the QIF 
it is apparent that participant 4 had a high level of functioning before the training began. 
This means that there may not have been a lot of room for improvement, indicating a 
possible ceiling effect. Participant I and participant 3 experienced greater increases in 
QIF scores than the other participants perhaps because they were at the optimal level for 
improvement, such that they had both the capacity and room for improvement. Looking 
specifically at the questions pertaining to upper limb function, participant 3 experienced 
an increase in the ability to turn from supine to side in bed, and participant 3 and 
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participant 4 experienced an increase in the ability to transfer from bed to chair. 
Functionally, even a small improvement in the abilitY to reposition in bed or transfer from 
bed to chair can cause a large improvement in quality of life. Repositioning in bed is 
important for pressure relief, and could prevent the complications associated with 
pressure sores, while going from the need for a transfer device to being abJe to transfer by 
oneself would increase independence. 
The mean total scores on the SCI-SET showed an increase of6.7%. This was non-
significant. Previous studies involving FES training have found ,no effect on spasticity 
(Skold et aI., 2002); however Adams and Hicks (2005) suggested that FES leg cycle 
ergometry may have an effect. Adams and Hicks (2005) predicted that properties of the 
spastic joint may be changed by strengthening the antagonist muscle. The current study 
cannot discount this theory, as no measures of strength were included, and the necessary 
gains in strength may not have been accomplished. As spasticity can have either a 
negative or positive effect on functional ability, it was hypothesized that the baseline 
SCI-SET scores indicating a negative effect would increase, and scores indicating a 
positive effect would stay the same. The mean total scores for the SCI-SET did show an 
increase in those items that were initially negative (thus moving towards the result of 
spasticity having no effect), however, the few scores that were initially positive also 
showed a decrease towards the result of spasticity having no effect. These changes were 
non-significant. Specifically, before the FES arm cycle ergometry training, participant I 
indicated that spasticity assisted with his positioning while lying down, and his ability to 
change positions while in bed, while after the training he found that his spasticity had no 
effect on these functions. Participant 3 found that prior to the FES training his spasticity 
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assisted with his ability to participate in therapeutic and exercise activities, and after 
training he found that his spasticity had no effect on his ability to complete these 
functions. Both the positive and negative effects of spasticity were found to move 
towards spasticity having no effect on function. To our knowledge this is the first use of 
the SCI-SET before and after an exercise intervention. It suggests that exercise may not 
always change muscle spasticity in a way that improves function, and more research is 
warranted. It is also important to note that the individual changes on certain items of the 
SCI-SET could be due to an actual exercise-induced decrease in spasticity, or just a 
change in the way spasticity interacted with functional movements (such as a change in 
timing or predictability of spasms). As no measure of spasticity was included in this 
study, we cannot determine which was the main cause for the observed changes. 
6.4.0 Relevance to the Current Literature & Clinical Relevance 
As FES arm cycle ergometry is a relatively new technology, there is little 
evidence of its effects. Coupaud et al. (2008) did a pilot study that looked only at 
individuals with a C6 spinal cord injury. The aim ofthe study was to determine the 
effects of FES arm cycle ergometry training on upper limb strength and cardiopulmonary 
fitness. Coupaud et al. concluded that FES arm cycle ergometry training had the potential 
to improve upper limb strength and cardiopulmonary fitness in some individuals with 
tetraplegia. Coupaud et al. (2008) stated that "The completeness of the injury, degree of 
disuse and denervation atrophy of the upper limb muscles prior to training, and the level 
of motivation behind the individual, are all likely to influence the potential for training 
effects in this group". The findings of the current study are complement to the fmdings of 
Coupaud et al. (2008) as they both suggest that FES arm cycle ergometry may be more 
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beneficial for some participants than others based on the completeness of the injury and 
pre-existing function. 
The results of the present study are important for individuals with tetraplegia due 
to the implications for the prevention of secondary health complications. The findings of 
this study show that FES arm cycle ergometry can be a beneficial form of'cardiovascular 
exercise for individuals with tetraplegia. This is important for decreasing the risk of 
developing cardiovascular disease in this population. FES arm cycle ergometry may have 
the potential to improve upper limb function in individuals who, have the capacity for 
improvement, depending on the completeness and level of injury, and pre-existing 
function. By improving upper limb function, individuals with tetraplegia could 
experience an increase in quality of life, based on their increased mobility, which results 
in a decrease in the risk for pressure sores, and increased independence. 
6.5.0 Limitations 
The main limitation of this study was the small number of participants. The 
current study included a good distribution of participants, and future large scale studies 
should continue to include a range of participants with regards to sex, age, level of injury, 
and completeness of injury. This would have given a better field for determining whether 
there was is a correlation between injury level and completeness and increases in upper 
limb function. This study did not include any participants with an ASIA A classification, 
so the results of this study may not be valid for these individuals. Another limitation of 
the study was that a duration of 12 weeks of training was used as the completion point, as 
opposed to the completion of 36 training sessions. This was done because of the need to 
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complete the training of some participants before holidays where lab access was not 
available, and the participants were not available. It would have been beneficial to have 
an equal number of sessions for each participant for analysis purposes, and some 
participants may not have reached the levels of improvement they had the potential to 
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reach. With regards to upper limb function, the measures used were self-reporting 
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questionnaires. This creates the potential for over or under reporting the benefits of 
function on spasticity. Questionnaires also are limited by ceiling effects, meaning that no 
improvement will be seen in individuals who have high scores to begin with, which limits 
the potential for significant change. The SCI-SET questionnaire was the only measure 
pertaining to spasticity in this study, and it only looked at the effect of spasticity on 
function. A limitation is that we have no data on whether the participants had any pre-
existing spasticity, and if they did not experience spasticity at any point, this would also 
limit the potential for significant change. 
6.6.0 Future Directions 
Further study is needed to determine the potential benefits of FES arm cycle 
ergometry on the upper limbs. Measures to determine changes in the upper limb muscles, 
such as manual muscle testing and muscle biopsies to look for changes in the muscle 
fibres would determine if FES arm cycle ergometry has effects on muscle similar to FES 
leg cycle ergometry. A measure of muscle spasticity, such as the Ashworth scale, should 
also be done in conjunction with the SCI-SET to determine ifFES arm cycle ergometry 
elicits changes in the spastic muscle, not just the effect on function. Further study to 
determine which specific groups would benefit from FES arm cycle ergometry should be 
done, as individuals should be aware before beginning an exercise program what positive 
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or negative effects to expect. While Coupaud et al. (2008) showed changes in 
cardiopulmonary function following 12 weeks ofFES arm cycle ergometry, these results 
were specific to individuals with a C6 spinal cord injury. Further study should be done 
into the effects of FES arm cycle ergometry on cardiopulmonary measures. 
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VII. CONCLUSION 
The current study shows that 12 weeks ofFES arm cycle ergometry results in a 
significant decrease in resting MAP in individuals with an incomplete spinal cord injury. 
FES arm cycle ergometry could be an effective exercise technique for decreasing the risk 
of cardiovascular disease in this population, due to the decrease in MAP . .J;:xercise 
performance showed a non-significant increase in the areas of time to fatigue, distance to 
fatigue, and work rate. These results could have been found to be non-significant due to 
the small sample size. FES arm cycle ergometry may also result in improvements in 
upper limb function and spasticity, depending on the level and completeness of injury. 
Future research into the effect of FES arm cycle ergometry on muscle and strength in the 
upper limbs should be done, and large scale studies should be done on the effect of FES 
arm cycle ergometry on cardiovascular health in individuals with tetraplegia. 
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Fig. 1. Time to fatigue (sec) during exercise to fatigue tests taken at baseline (pre), 6 
weeks (mid), and following 12 weeks (post) ofFES arm cycle ergometry training in 
individuals with tetraplegia. 
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Fig. 2. Distance to fatigue (miles) during exercise to fatigue tests taken at baseline (pre), 
6 weeks (mid), and following 12 weeks (post) ofFES arm cycle ergometry training in 
individuals with tetraplegia. 
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Fig. 3. Work rate (kcallhr) during exercise to fatigue tests taken at baseline (pre), 6 weeks 
(mid), and following 12 weeks (post) ofFES arm cycle ergometry training in individuals 
with tetraplegia. 
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Fig. 4. Mean Arterial Pressure (mmHg) at exercise to fatigue tests taken at baseline and 
following 12 weeks (post) ofFES arm cycle ergometry training in individuals with 
tetraplegia. 
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Fig. 5. Resting heart rate (bpm) at exercise to fatigue tests taken at baseline (pre), and 
following 12 weeks (post) ofFES arm cycle ergometry in individuals with tetraplegia. 
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Fig. 6. Work intensity (kcallhr/HR) during exercise to fatigue tests taken at baseline (pre) 
and following 12 weeks (post) ofFES arm cycle ergometry training in individuals with 
tetraplegia. 
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Fig. 7. Capabilities of Upper Extremity Questionnaire scores taken at baseline (pre) and 
following 12 weeks (post) ofFES arm cycle ergometry in individuals with tetraplegia. 
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Fig. 8. Capabilities of Upper Extremity Questionnaire shoulder function scores taken at 
baseline (pre) and following 12 weeks (post) ofFES arm cycle ergometry in individuals 
with tetraplegia. 
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Fig. 9. Capabilities of Upper Extremity Questionnaire biceps function scores taken at 
baseline (pre) and following 12 weeks (post) ofFES arm cycle ergometry in individuals 
with tetraplegia. 
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Fig. 10. Capabilities of Upper Extremity Questionnaire triceps function scores taken at 
baseline (pre) and following 12 weeks (post) ofFES arm cycle ergometry in individuals 
with tetraplegia. 
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Fig. 11. Quadriplegia Index of Function total scores taken at baseline (pre) and following 
12 weeks (post) of FES arm cycle ergometry in individuals with tetraplegia. 
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Fig. 12. Spinal Cord Injury Spasticity Evaluation Tool total scores taken at baseline (pre) 
and following 12 weeks (post) ofFES arm cycle ergometry in individuals with 
tetraplegia. 
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UPPER EXTREMITY CAPABILITY QUESTIONNAIRE 
Read the following instructions to the patient and be sure 
he/she understands the responses before proceeding to the 
questions. 
This questionnaire is designed to find out how well you are 
able to use your arms and hands. I will ask you about a number 
of actions which some people with spinal cord injury have 
limitations performing. Please consider whether, on an average 
day, you have difficulties or limitations performing these 
actions. By this I mean difficulty doing the action, or trouble 
doing it as often as you would like or need in order to complete 
everyday activities. Consider only the specific part of your arm 
or hand asked about in each question. For example, if asked 
about pulling something with your arm, do not worry about 
whether or not you can grab it with your hand. 
Pick one of the following responses to indicate how much, if 
any, limitation you have: 
7. Not at all limited 
6. A little limited 
5. Some limitation 
4. Moderately limited 
3. Very limited 
2. Extremely limited 
1. Totally limited, can't do it at all 
The following questions are about your ability to reach or lift: 
1. Think about reaching out with your arm to touch 
something directly in front of you that is at shoulder 
level: 
a. How limited are you doing this using your RIGHT 
ARM? 
b. How limited are you doing this using your LEFT 
ARM? 
2. Think about raising your arm directly over your head, 
with your arm straight: 
a. How limited are you doing motion using your RIGHT 
ARM? 
b. How limited are you doing motion using your LEFT 
ARM? 
3. Think about reaching down to touch the floor and sitting 
back up straight, without hooking with your other arm or 
using it to pull yourself up: 
a. How limited are you doing this with your RIGHT 
HAND? 
b. How limited are you doing this with your LEFT 
HAND? 
4. Think about raising a 5-pound object like a heavy 
blanket over your head using both arms. (Don't worry 
about whether you could grab it with your hands, just if 
you could raise something that heavy over your head.): 
How limited are you doing this using BOTH ARMS? 
The following questions are about your ability to pull and push 
with your arms: 
5. Think about pulling or sliding (without grasping) a light 
object such as a can of soda, that is on a table, towards 
you: 
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a. How limited are you doing this kind of thing using 
your RIGHT ARM? 
b. How limited are you doing this kind of thing using 
your LEFT ARM? 
Think about pulling or sliding (without grasping) a 
heavy object (up to 10 Ibs.), that is on a table, towards 
you: 
a. How limited are you doing this kind of thing using 
your RIGHT ARM? 
b. How limited are you doing this kind of thing using 
your LEFT ARM? 
Think about pushing a light object such as a can of soda 
on a table, away from you: 
a. How limited are you doing this kind of thing using 
your RIGHT ARM? 
b. How limited are you doing this kind of thing using 
your LEFT ARM? 
Think about pushing a heavy object (up to 10 Ibs.) on a 
table, away from you: 
a. How limited are you doing this kind of thing using 
your RIGHT ARM? 
b. How limited are you doing this kind of thing using 
your LEFT ARM? 
Think about pushing down with both arms into your 
chair enough to lift your buttocks (both sides) off the seat 
(do a push-up weight shift): 
How limited are you doing this? 
The following questions are about moving and positioning your 
arm and wrist: 
10. With your hand on your lap palm down, think about 
curling your wrist upwards, keeping your arm on your 
lap: 
a. How limited are you doing this motion using your 
RIGHT HAND? 
11 
b. How limited are you doing this motion using your 
LEFT HAND? 
Think about turning your hand over-from your palm 
facing up to facing the floor, keeping your elbow bent at 
your side (the arm motion someone would make when 
turning a doorknob or a dial): 
a. How limited are you doing this motion using your 
RIGHT ARM? 
b. How limited are you doing this motion using your 
LEFT ARM? 
The following questions are about using your hands and fingers: 
12. Think about grasping and holding an object like a 
hammer with your hand: 
a. How limited are you doing this kind of thing using 
your RIGHT HAND? 
b. How limited are you doing this kind of thing using 
your LEFT HAND? 
13. Think about picking up a small object such as a paper 
clip or the cap of a tube of toothpaste with the tips of 
your thumb and first two fingers: 
a. How limited are you doing this kind of thing using 
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your RIGHT HAND? 
b. How limited are you doing this kind of thing using 
your LEFT HAND? 
14. Think about pinching and holding an object between 
your thumb and the side of your index finger, such as 
holding a key: 
a. How limited are you doing this kind of thing using 
your RIGHT HAND? 
b. How limited are you dOing this kind of thing using 
your LEFT HAND? 
15. Think about grasping a large object like the lid of a 2 
pound jar of mayonnaise with the tips of the fingers hard 
enough to pick the jar up or open the lid: 
a. How limited are you doing this kind of thing using 
your RIGHT HAND? 
b. How limited are you doing this kind of thing using 
your LEFT HAND? . 
16. Think about using your fingers to manipulate objects, 
such as holding a coin and turning it over and over with 
your fingers: 
a. How limited are you doing this kind of thing using 
your RIGHT HAND? 
b. How limited are you doing this kind of thing using 
your LEFT HAND? 
17. Think about pressing something with the tip of your 
index finger (not knuckle) such as dialing a touch-tone 
phone or ringing a doorbell: 
a. How limited are you doing this kind of thing using 
your RIGHT HAND? 
b. How limited are you doing this kind of thing using 
your LEFT HAND? 
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Short·form of the Quadriplegia Index of Function Scale 
Please indicate your level of independence for the following activities of daily living. 
1. Opening a carton/jar 
o = Dependent 
1 = Assistance needed 
2 = Supervision required 
3 = Independent with devices 
4 = Independent 
2. Washing/drying your hair 
o = Dependent 
1 = Assistance needed 
2 = Supervision required 
3 = Independent with devices 
4 = Independent 
3. Dressing your lower body 
o = Dependent 
1 = Assistance needed 
2 = Supervision required 
3 = Independent with devices 
4 = Independent 
4. Turning from supine to your side in bed 
o = Dependent 
1 = Assistance needed 
2 = Supervision required 
3 = Independent with devices 
4 = Independent 
5. Transferring from bed to wheelchair 
o = Dependent 
1 = Assistance needed 
2 = Supervision required 
3 = Independent with devices 
4 = Independent 
6. Locking your wheelchair wheels 
o = Dependent 
1 = Assistance needed 
2 = Supervision required 
3 = Independent with devices 
4 = Independent 
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For each of the following, please choose the answer that best describes how your spasticity symptoms have 
affected that area of your life during the past 7 days. When I talk about "spasticity symptoms", I mean: 
a) uncontrolled, invohmtary muscle contraction or movement (slow or rapid; short or prolonged), 
b) involuntary. repetitive, quick muscle movement (up and down; side to side), c) muscle tightness, and 
d) what you might descnoe as "spasms". Please let me know when a question is not applicable to you. 
-3 .. 2 -1 o +1 +2 +3 
DURlNG THE PAST 7 DAYS, HOW HA VB YOUR SPASTICI1Y SYMPTOMS AFFECTED: 
1. your showering? -3 -2 -1 0 +1 +2 +3 NfA 
2. your dressinglundressing? -3 -2 -1 0 +1 +2 +3 NIA 
3. your transfers (to and from bed, chair, vehicle, etc.)? -3 -2 -1 0 +1 +2 +3 N/A 
4. your sitting positioning (in your chair, etc.)? -3 -2 -1 0 +1 +2 +3 N/A 
5. the preparation of meals? -3 -2 -1 0 +1 +2 +3 N/A 
6. eating? -3 -2 -1 0 +1 +2 +3 N!A 
7. drinking? -3 -2 -1 0 +1 +2 +3 N/A 
8.yoursmallhandmovements(writing,useofcomputer,etc.)? -3 -2 -1 0 +} +2 +3 N/A 
9. your ability to perfunn household chores? -3 -2 -1 0 +1 +2 +3 N/A 
to. your hobbies/recreational activities? -3 -2 -1 0 +1 +2 +3 N!A 
11. your enjoyment of social outings? -3 -2 -I 0 +1 +2 +3 N/A 
12. your ability to stand/weight-bear? -3 -2 -1 0 +1 +2 +3 N/A 
13. your walking ability? -3 -2 -1 0 +1 +2 +3 NfA 
14, your stabilitylbalance? ·3 -2 -1 0 +1 +2 +3 N/A 
15. your muscle fatigue? -3 -2 -1 0 +1 +2 +3 N/A 
16. the flexibility of your joints? ~3 ~2 -1 0 +1 +2 +3 N/A 
17. your therapy/exercise routine? -3 -2 -1 0 +1 +2 +3 N/A 
18. yourmallual wheelchair use? -3 -2 -1 0 +1 +2 +3 N/A 
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o +1 +2 +3 
DURING THE PAST 7 DAYS, HOW HAVE YOUR SPASTICITY SYMPTOMS AFFECTED: 
19. your pmver wheelchair use? -3 -2 -1 0 +1 +2 +3 NfA 
20. your lyillg positioning (in hed, etc.)? ·3 -2 -1 0 +1 +2 +3 N!A 
lL your ahility to change positiolls in bed? -3 -2 -1 0 +1 +2 +3 N/A 
22. your ability to get to sleep? ·3 ·2 -1 0 +l +2 +3 N!A 
23. the quality ofyolU" sleep? '" oj> -2 -I 0 +1 +2 1<3 N!A 
24. your sex life? -3 -2 -1 0 +1 +2 +3 NtA 
25. the feeling of being annoyed'? -3 -2 -I 0 +l +2 +3 WA 
26. the feeling of being emharrassed? -3 -2 -1 0 +1 +2 +3 N/A 
27. your feeling of C<lll1folt socially? -3 -2 -1 0 +1 +2 +3 NlA 
28. your feeling of comfOlt physically? ·3 ·2 -I 0 +1 +2 +3 N/A 
29. your pain? -3 -2 -1 0 +1 +2 +3 NtA 
30. your concem with falling? -3 -2 -1 0 +1 +2 +3 N!A 
31. your concemwith getting Injured? -3 -2 -1 0 +1 +2 +3 NiA 
32. your C011ce111 with accidenlully irtiuring someone else? -3 -2 -1 0 +1 +2 +3 N!A 
33. your ahility to concentrate? -3 -2 -I 0 +1 +2 +3 Nt'A 
34. your feelings of control over your hody? .. -;:l -2 -1 0 +1 +2 +3 N/A 
35. you!" need to ask tor help? -3 -2 -1 0 +1 +2 +3 NfA 
Nm:nber of ( +) items: Negati.ve score: 
N muher of ( -) items: Positive score: 
Nmllber of (0) items: Total score: 
Applicable items (#): 
Average score: 
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df MS 
effect effect df error MS error F p-Ievel 
MAP 2 114.902 8 242.1262 0.474554 0.638618 
df MS 
effect effect df error MS error F p-Ievel 
RestingHR 2 114.2 8 55.61666 2.053341 0.19066 
df MS 
effect effect df error MS error F p-Ievel 
Time to Fatigue 2 592000.8 8 327206.2 1.809259 0.22478 
df MS 
effect effect df error MS error F p-Ievel 
Distance to 
fatigue 2 7.4115 8 5.058925 1.465035 0.286991 
df MS 
effect effect df error MS error F p-Ievel 
Kcal/hr 
expended 2 7.76958 8 6.45168 1.204272 0.34898 
df MS 
effect effect df error MS error F p-Ievel 
AvgHR 2 5.066667 8 27.06667 0.187192 0.832815 
df MS 
effect effect df error MS error F p-Ievel 
Peak HR 2 6.066667 8 24.65 0.246112 0.787543 
df MS 
effect effect df error MS error F p-Ievel 
CUE Total 2 176.2667 8 350.4333 0.502996 0.622635 
df MS 
effect effect df error MS error F j>-Ievel 
QIF Total 2 11.26667 8 22.35 0.504101 0.622024 
df MS 
effect effect df error MS error F p-Ievel 
SCI-SET 2 72.86667 8 51.36666 1.418559 0.296965 
df MS 
effect effect df error MS error F p-Ievel 
CUE 1,2,4 2 4.2 8 1~.03333 0.232902 0.79742 
df MS 
effect effect df error MS error F p-Ievel 
CUE3 2 6.066667 8 2.566667 2.363636 0.156106 
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df MS 
effect effect df error MS error F p~level 
CUE 5,6 2 7.4 8 7.566667 0.977974 0.416898 
df MS 
effect effect df error MS error F p-Ievel 
CUE 7,8,9 2 0.8 8 4.383333 0.18251 0.836551 
df MS 
effect effect df error MS error F p:.level 
CUE 10,11 2 0.866667 8 6.533333 0.132653 0.877656 
df MS 
effect effect df error MS error F p-Ievel 
CUE 12-17 2 75.26667 8 48.6 1.548697 0.27007 
df MS 
effect effect df error MS error F p-Ievel 
QIF 1 2 2.066667 8 1.733333 1.192308 0.352207 
df MS 
effect effect df error MS error F p-Ievel 
QIF2 2 0.466667 8 1.05 0.444444 0.6561 
df MS 
effect effect df error MS error F p-Ievel 
QIF3 2 0.6 8 1.266667 0.473684 0.639114 
df MS 
effect effect df error MS error F p-Ievel 
QIF4 2 0.466667 8 1.633333 0.286714 0.758835 
df MS 
effect effect df error MS error F p-Ievel 
QIF 5 2 0.6 8 0.35 1.714286 0.2401 
df MS 
effect effect df error MS error F p-Ievel 
QIF6 2 0.6 8 1.266667 0.473684 0.639114 
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Exercise Performance Data 
Time to Fatigue 
(seconds) Pre Mid Post 
1 608 608 679 
2 608 615 672 
3 693 650 2700 
4 1444 2700 2700 
5 670 668 668 
AVG 804.6 1048.2 1483.8 
STDEV 359.4117 923.71489 1110.241 
Distance to 
Fatigue (milesl Pre Mid Post 
1 1.02 1.02 1.34 
2 0.97 1.18 1.27 
3 2.06 1.44 9 
4 6 12 10.7 
5 0.83 0.64 0.72 
AVG 2.176 3.256 4.606 
STDEV 2.19311 4.89664 4.83065 
Kcal/Hr Expended Pre Mid Post 
1 1.27 1.03 2.25 
2 0.95 1.84 1.88 
3 9.84 6.22 17.44 
4 5.4 5.7 5.1 
5 0.5 0.5 0.5 
AVG 3.592 3.058 5.434 
STDEV 4.007452 2.698059 6.916804 
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Cardiovascular Performance Data 
" 
Resting HR Pre Mid Post 
1 61 74 65 
2 57 83 57 
3 77 89 82 
4 70 73 78 
5 69 62 68 
AVG 66.8 76.2 70 
STDEV 7.886698 10.32957 10.07472 
p= 0.125355 
AvgHR Pre Mid Post 
1 74 70 74 
2 63 60 61 
3 96 95 84 
4 84 90 80 
5 80 86 92 
AVG 79.4 80.2 78.2 
STDEV 12.19836 14.669697 11.62755 
p= 0.7724458 
PeakHR Pre Mid Post 
1 79 77 89 
2 68 65 65 
3 107 103 102 
4 96 94 85 
5 89 90 97 
AVG 87.8 85.8 87.6 
STDEV 15.05656 14.92314 14.27585 
p= 0.962449 
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Kcal/hr/HR Pre Mid Post 
1 0.017 0.015 0.03 
2 0.015 0.03 0.031 
3 0.044 0.065 0.21 
4 0.064 0.063 0.063 
5 0 0.0056 0.0054 
AVG 0.028 0.03572 0.06788 
STDEV 0.025622 0.027252 0.082038 
p= 0.276411 
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Upper Limb Function Data 
CUE TOTAL Pre Mid Post 
1 106 107 124 
2 158 179 133 
3 162 193 164 
4 131 138 178 
5 41 39 39 
AVG 119.6 131.2 127.6 
STDEV 49.40951 61.718717 54.21531 
p= 0.5391849 
CUE q1,2,4 Pre Mid Post 
1 13 24 24 
2 29 23 23 
3 34 33 31 
4 19 19 27 
5 7 6 6 
AVG 20.4 21 22.2 
STDEV 11.12654 9.8234414 9.576012 
p= 0.6120552 
CUE q5,6 Pre Mid Post 
1 26 24 24 
2 26 16 16 
3 26 28 26 
4 20 20 22 
5 7 7 6 
AVG 21 19 18.8 
STDEV 8.246211 8.0622577 8.074652 
p= 0.3455239 
CUE q7,8,9 Pre Mid Post 
1 24 25 21 
2 32 28 28 
3 33 35 33 
4 22 21 26 
5 8 8 7 
AVG 23.8 23.4 23 
STDEV 10.05982 10.014989 9.924717 
p= 0.5964759 
81 
QIFTOTAL Pre Mid Post 
1 2 9 4 
2 1 0 0 
3 14 15 19 
4 22 7 23 
5 0 0 0 
AVG 7.8 6.2 9.2 
STDEV 9.757049 6.379655 10.98636 
p= 0.245492 
QIF q2 Pre Mid Post 
1 0 1 0 
2 0 0 0 
3 3 0 4 
4 3 3 3 
5 0 0 0 
AVG 1.2 0.8 1.4 
STDEV 1.643168 1.30384 1.949359 
p= 0.373901 
QIFq5 Pre Mid Post 
1 0 1 0 
2 0 0 0 
3 2 4 4 
4 3 3 4 
5 0 0 0 
AVG 1 1.6 1.6 
STDEV 1.414214 1.81659 2.19089 
p= 0.208 
SCI-SET TOTAL Pre Mid Post 
1 131 140 144 
2 129 128 133 
3 130 143 127 
4 96 110 120 
5 127 121 125 
AVG 122.6 128.4 129.8 
STDEV 14.94323 13.61249 9.20326 
p= 0.22886 
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Participant 1 Data 
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Exercise Performance Data 
Time to Fatigue: 
Pre 10:08 
Mid 10:08 
Post 11 :19 
Distance to 
Fatigue: 
Pre 1.02 
Mid 1.02 
Post 1.34 
Kcallhr 
Expended: 
Pre 1.27 
Mid 1.03 
Post 2.25 
Cardiovascular Performance Data 
MAP Resting BP Resting HR 
Pre 79.3 90/58 61 
Mid 64.3 85/54 74 
Post 77.7 84/65 65 
Avg HR: Peak HR: 
Pre 74 Pre 79 
Mid 70 Mid 77 
Post 74 Post 89 
Upper Limb Function Data 
QIF 
? Pre Mid Post 
1 2 4 4 
2 0 1 0 
3 0 1 0 
4 0 1 0 
5 0 1 0 
6 0 1 0 
AVG 0.333333 1.5 0.666667 
STD 0.816497 1.224745 1.632993 
SUM 2 9 4 
84 
CUE 
? Pre Mid Post 
1a 5 6 7 
1b 3 3 4 
2a 2 5 6 
2b 1 2 3 
3a 1 1 1 
3b 1 1 1 
4 2 5 4 
Sa 7 7 7 
5b 6 5 5 
6a 6 5 7 
6b 7 3 5 
7a 7 7 7 
7b 6 5 6 
8a 6 5 7 
8b 4 3 4 
9 1 1 1 
10a 1 1 1 
10b 1 1 1 
11a 7 6 7 
11b 7 6 4 
12a 1 1 1 
12b 1 1 1 
13a 4 1 6 
13b 3 1 3 
14a 1 1 1 
14b 1 1 1 
15a 1 1 1 
15b 1 1 1 
16a 1 6 6 
16b 1 2 3 
17a 6 7 7 
17b 4 6 5 
AVG 3.3125 3.34375 3.875 
SO 2.455245 2.322532 2.432972 
SUM 106 107 124 
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SCi-
SET 
? Pre Mid Post 
1 5 4 7 
2 3 4 4 
3 4 3 4 
4 3 4 4 
5 4 4 4 
6 4 4 4 
7 4 4 4 
8 4 4 4 
9 4 4 4 
10 3 4 4 
11 4 4 4 
12 1 4 4 
13 4 4 4 
14 4 4 4 
15 4 4 5 
16 3 3 4 
17 3 4 4 
18 3 4 4 
19 4 4 4 
20 5 5 4 
21 5 6 4 
22 4 4 4 
23 4 4 4 
24 4 4 4 
25 3 4 4 
26 3 3 4 
27 4 4 4 
28 4 4 4 
29 4 4 4 
30 4 4 4 
31 4 4 4 
32 4 4 4 
33 4 4 4 
34 3 4 4 
35 4 4 4 
AVG 3.742857 4 4.114286 
SD 0.741337 0.485071 0.529785 
SUM 131 140 144 
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Training Resting Resting Peak Avg 
Data 1 BP HR Resistance Distance Time HR HR BP Post Cal Cal/hr 
Pre 90158 61 1 1.02 10.08 79 74 89/52 0.2 1.3 
1 85/62 69 1 1 9.28 98 84 70/58 0.2 1.1 
1 1.1 10.12 97 89 93/82 0.2 1.4 
1 1.1 10.08 88 76 131/69 0.2 1.5 
1a 82162 71 1 0.97 10.08 93 83 75/50 0.13 0.75 
1 0.96 10.08 86 76 90/53 0.1. 0.87 
1 0.98 10.08 79 70 95/48 0.15 0.87 
2 89/48 67 1 1 9.38 86 ,77 90/51 0.11 0.67 
1 1.13 10.08 89 80 130/62 0.27 1.58 
1 1.1 10.1 84 74 95/55 0.25 1.48 
3 63/54 72 1 1.09 10.08 81 75 75/50 0.21 1.24 
1 1.06 10.1 81 73 72/50 0.19 1.09 
1 1.07 10.09 91 76 70/50 0.21 1.27 
4 103/61 64 1 1.1 10.09 88 74 120/90 0.19 1.15 
1 1.07 10.11 83 74 129/74 0.23 1.36 
1 1.13 10.08 84 75 90/49 0.3 1.76 
5 81/61 70 1 1.13 10.1 150/115 0.28 1.66 
1 1.15 10.2 83 75 80/62 0.29 1.7 
1 1.15 10.42 78 70 73/52 0.25 1.42 
6 73/54 80 1 1.21 10.13 99 86 96/65 0.31 1.85 
1 1.05 10.08 92 83 79/55 0.19 1.13 
1 1.19 10.18 102 85 79/59 0.33 1.93 
7 106/65 63 1 1.19 10.31 83 73 77/45 0.32 1.82 
1 1.11 10.11 79 70 74/48 0.25 1.45 
1 1.23 10.25 98 67 116/49 0.38 2.21 
8 82/61 55 1 1.11 10.12 70 63 87/47 0.21 1.21 
1 1.11 10.14 76 68 86/52 0.24 1.4 
1 1.06 10.08 70 65 100/82 0.21 1.24 
9 119/105 97 1 1.12 10.48 90 79 80/61 0.23 1.26 
1 1.05 10.11 85 79 81/41 0.17 1.02 
1 1.2 11.17 86 78 78/44 0.27 1.43 
10 88/54 71 1 1.04 10.08 82 73 90/54 0.18 1.09 
1 1.05 10.08 78 66 126/60 0.2 1.17 
1 1.1 10.1 77 66 90/38 0.21 1.4 
11 118/66 71 1 1.14 10.09 93 77 70/51 0.29 1.69 
1 1.2 10.34 87 73 95/55 0.34 1.91 
1 1.18 10.08 93 66 92/58 0.32 1.92 
12 87/62 63 1 1.03 10.08 83 78 86/53 0.18 1.09 
1 1.02 10.08 72 66 106/50 0.16 0.93 
1 1.07 10.17 88 73 84/38 0.17 1.02 
13 98/67 72 1 1.11 10.12 87 78 110/66 0.26 1.55 
1 1.08 10.08 90 73 137171 0.21 1.26 
1 1.03 10.1 76 68 76/41 0.17 1.01 
14 102/61 49 1 1.08 10.1 78 69 107/55 0.22 1.32 
1 1.02 10.08 78 66 82/60 0.15 0.86 
1 0.96 10.08 66 57 92/52 0.15 0.91 
85/54 74 1 1.02 10.08 77 70 79/51 0.17 1.03 
87 
Mid 
1 1.01 10.08 70 58 86/50 0.15 0.92 
1 1.01 10.08 70 60 76/42 0.17 0.99 
16 83/51 60 1 0.94 10.08 83 68 75/46 0.14 0.83 
1 0.98 10.1 72 66 78/51 0.15 0.88 
1 0.98 10.08 72 62 77/37 0.14 0.86 
17 86/48 73 1 0.98 10.08 92 75 103/63 0.15 0.9 
1 0.98 10.08 88 68 61/40 0.1' 1.09 
1 1 10.08 89 72 93/72 0.1 i' 1 
18 99/66 63 1 1.03 10.08 69 '62 98/58 0.21 1.23 
1 1.01 10.08 67 58 94/62 0.19 1.1 
1 1.03 10.09 63 57 90/66 0.19 1.12 
19 70/46 65 1 0.99 10.08 74 70 80/54 0.17 0.99 
1 0.99 10.08 73 63 75/62 0.17 0.99 
1 1 10.08 74 64 77/57 0.16 0.92 
20 128/47 72 1 0.98 10.08 83 71 158/81 0.18 1.07 
1 1.03 10.08 69 60 88/73 0.17 0.99 
1 1 10.08 68 58 88/51 0.13 0.76 
21 84/54 71 1 0.95 10.08 84 78 70/46 0.18 1.04 
1 0.98 10.08 76 70 77/62 0.14 0.82 
1 0.98 10.08 75 68 64/54 0.14 0.82 
22 90/54 64 1 1.04 10.08 74 70 86/47 0.17 1 
1 1.01 10.08 73 73 78/42 0.18 1.09 
1 1.03 10.08 80 64 82/42 0.19 1.12 
23 102/58 50 1 1.01 10.07 69 63 78/50 0.15 0.89 
1 1.04 10.08 59 54 89/48 0.18 1.1 
1 1.07 10.08 64 56 90/54 0.23 1.39 
24 82/66 65 1 1.09 10.12 74 64 71/54 0.23 1.35 
1 1.07 10.08 74 61 83/62 0.22 1.28 
1 1.09 10.08 78 56 98/54 0.24 1.41 
25 90/61 60 1 1.02 10.13 66 56 81/42 0.23 1.35 
1 1.08 10.08 61 54 86/60 0.21 1.24 
1 1.07 10.08 63 54 112/93 0.18 1.07 
26 97/30 63 1 1.05 10.08 83 71 134/92 0.22 1.33 
1 1.07 10.09 73 63 84/54 0.19 1.1 
1 1.15 10.17 85 67 85/58 0.3 1.78 
27 95/67 74 1 1.13 10.11 71 60 82/49 0.29 1.72 
1 1.05 10.08 73 58 87/50 0.23 1.35 
1 1.05 10.09 59 105/37 0.22 1.27 
28 111/81 69 1 1.12 11.08 77 57 82/54 0.22 1.21 
1 1.11 11.08 76 59 86/68 0.21 1.13 
1 1.08 11.08 71 57 138/113 0.18 0.96 
29 92/66 65 1 1.09 11.08 66/54 0.18 0.96 
1 1.06 11.09 69 63 122/56 0.21 1.15 
1 1.08 11.08 69 63 52/42 0.22 1.21 
30 98/62 68 1 1.14 11.08 72 62 73/61 0.2 1.09 
1 1.12 11.08 78 64 94/56 0.22 1.17 
1 1.14 11.08 91 70 86/52 0.23 1.24 
88 
31 86/55 60 1 1.11 11.09 72 66 0.17 0.94 
1 1.11 11.08 66 59 144/125 0.19 1.01 
1 1.07 11.08 76 58 130/103 0.2 1.08 
32 85/62 59 1 1.07 11.08 75 63 86/53 0.19 1.04 
1 1.07 11.08 67 56 90/48 0.19 1.04 
1 1.06 11.08 71 57 70/56 0.19 1.04 
33 100/66 52 1 1.15 11.12 66 56 90/58 0.2 1.07 
1 1.11 11.09 60 50 83/58 0.2. 1.17 
1 1.13 11.07 66 51 84/53 0.1~ 1.04 
34 94/56 65 1 1.13 11.09 81 '72 74/43 0.19 1 
1 1.13 11.08 80 63 84/53 0.23 1.21 
1 1.13 11.08 81 69 81/51 0.23 1.22 
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Exercise Performance Data 
Time to Fatigue: 
Pre 10:08 
Mid 10:15 
Post 11 :12 
Distance to 
Fatigue: 
Pre 0.97 
Mid 1.18 
Post 1.27 
Kcal/hr Expended: 
Pre 0.95 
Mid 1.84 
Post 1.88 
Cardiovascular Performance Data 
MAP Resting BP Resting HR 
Pre 112.3 126/85 57 
Mid 96 109/70 83 
Post 110 124/82 57 
Avg HR: Peak HR: 
Pre 63 Pre 68 
Mid 60 Mid 65 
Post 61 Post 65 
Upper Limb Function Data 
QIF 
? Pre Mid Post 
1 0 0 0 
2 0 0 0 
3 0 0 0 
4 1 0 0 
5 0 0 0 
6 0 0 0 
AVG 0.166667 0 0 
STD 0.408248 0 0 
SUM 1 0 0 
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CUE 
? Pre Mid Post 
1a 6 6 4 
1b 6 6 4 
2a 5 7 5 
2b 5 6 4 
3a 4 5 4 
3b 4 6 4 
4 7 6 6 
5a 7 7 4 
5b 7 7 4 
6a 6 6 4 
6b 6 6 4 
7a 7 7 6 
7b 7 7 6 
8a 6 7 6 
8b 6 7 6 
9 6 6 4 
10a 7 7 4 
10b 7 7 4 
11a 6 7 6 
11b 6 7 6 
12a 4 5 4 
12b 4 5 3 
13a 3 5 4 
13b 4 5 4 
14a 3 6 3 
14b 5 6 3 
15a 2 6 4 
15b 5 6 3 
16a 2 4 3 
16b 3 3 3 
17a 1 2 2 
17b 1 2 2 
AVG 4.9375 5.78125 4.15625 
STD 1.830521 1.385044 1.167003 
SUM 158 179 133 
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SCI-
SET 
? Pre Mid Post 
1 4 4 4 
2 4 4 4 
3 4 3 4 
4 3 3 4 
5 4 4 4 
6 4 4 4 
7 4 4 4 
8 3 4 4 
9 4 4 4 
10 4 4 4 
11 4 4 4 
12 3 3 4 
13 3 3 4 
14 3 3 4 
15 4 3 3 
16 4 4 3 
17 4 4 4 
18 4 4 4 
19 4 4 4 
20 3 3 3 
21 3 3 3 
22 4 4 3 
23 4 4 3 
24 4 4 4 
25 4 4 4 
26 4 4 4 
27 4 4 4 
28 4 4 4 
29 3 3 3 
30 3 3 4 
31 3 3 4 
32 3 3 4 
33 4 4 4 
34 4 4 4 
35 4 4 4 
AVG 3.685714 3.657143 3.8 
STO 0.471008 0.481594 0.40584 
SUM 129 128 133 
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Training Resting Resting Peak Avg BP 
Data 2 BP HR Resistance Distance Time HR HR Post Cal Cal/hr 
Pre 126/85 57 1 0.97 10.08 68 63 112/66 0.16 0.95 
1 102/57 58 1 1.01 10.08 71 66 101/62 0.18 1.07 
1 0.98 10.08 74 66 99/60 0.16 0.93 
1 0.96 10.08 67 62 102/62 0.21 1.25 
2 115/65 53 1 1 10.08 64 58 107/69 0.2 1.16 
1 1 10.08 57 52 114/72 0.19. 1.14 
1 1.04 10.08 58 52 105/68 0.22' 1.29 
3 99/67 65 1 0.93 10.08 72 -67 104/58 0.17 1.03 
1 0.95 10.08 68 63 98/61 0.12 0.71 
1 0.98 10.08 66 60 111/64 0.13 0.77 
4 118/59 56 1 0.99 10.08 62 57 105/68 0.16 0.95 
1 1.12 10.42 58 55 109/58 0.21 1.16 
1 1.09 10.41 64 56 112/72 0.22 1.26 
5 106/70 58 1 1.02 10.08 64 60 98/62 0.23 1.35 
1 1.02 10.08 66 60 95/66 0.17 0.98 
1 1.04 10.08 64 58 104/62 0.19 1.14 
6 91/67 59 1 1.02 10.08 63 59 115/64 0.22 1.3 
1 1.03 10.08 103/62 0.18 1.09 
1 1.04 10.08 59 56 111/82 0.22 1.28 
7 110/67 54 1 0.96 10.08 61 59 108170 0.14 0.81 
1 1 10.08 56 54 110/70 0.15 0.91 
1 1.07 10.08 112/70 0.25 1.49 
8 99/78 57 1 0.96 10.08 63 60 91/70 0.22 1.28 
1 0.99 10.08 61 57 111/69 0.19 1.11 
1 1.02 10.08 60 57 109/69 0.2 1.19 
9 124/73 80 1 1.06 10.08 108/47 0.25 1.47 
1 1.02 10.08 110/70 0.26 1.54 
1 1.05 10.08 122/69 0.24 1.44 
10 107/61 58 1 0.98 10.08 68 64 117/70 0.17 1 
1 1.02 10.08 111170 0.27 1.59 
1 1.02 10.08 61 58 112/73 0.24 1.39 
11 116/70 53 1 1.03 10.08 61 56 110/62 0.17 1 
1 1.02 10.08 59 53 119/74 0.22 1.29 
1 1.06 10.08 59 54 111/71 0.24 1.4 
12 116/73 60 1 1.06 10.08 65 60 106/69 0.25 1.5 
1 1.04 10.08 64 57 108175 0.25 1.5 
1 1.04 10.08 62 57 118/69 0.25 1.48 
13 93/62 56 1 1.15 10.08 63 56 105/64 0.3 1.75 
1 1.11 10.1 57 53 109/69 0.26 1.51 
1 1.07 10.08 60 54 113/76 0.23 1.38 
14 106/87 59 1 1.12 10.1 64 59 98/64 0.27 1.58 
1 0.98 10.08 62 58 109/64 0.23 1.34 
1 1.14 10.09 59 55 110/73 0.29 1.73 
Mid 109/70 83 1 1.18 10.15 65 60 111175 0.31 1.84 
15 96/74 59 1 0.36 3.15 61 58 83/66 0.07 1.25 
1 1.1 10.09 62 55 100/70 0.2 1.4 
1 1.1 10.08 112/72 0.2 1.4 
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1 1.2 10.08 58 56 104/74 0.3 2 
16 118/65 61 1 1.15 10.11 64 60 113/68 0.32 1.88 
1 1.09 10.08 59 56 110/74 0.26 1.52 
1 1.07 10.11 61 58 108/70 0.24 1.41 
17 104/70 63 1 1 10.09 67 65 123/68 0.23 1.36 
1 1.03 10.07 64 62 122/78 0.21 1.24 
1 1.06 10.08 120/83 0.25 1.45 
18 118/67 54 1 1.11 10.07 61 57 102/70 0.26'~i 1.55 
1 1.09 10.08 58 55 101/69 0.29 1.74 
1 1.11 10.19 57 '54 114/72 0.29 1.7 
19 110/70 63 1 1.07 10.08 73 65 107/71 0.25 1.5 
1 1.11 10.1 69 63 108/66 0.29 1.73 
1 1.17 10.15 67 63 106/69 0.37 2.16 
20 147/78 57 1 1.22 11.08 63 59 119/74 0.33 1.76 
1 1.18 11.09 61 56 113/69 0.28 1.51 
1 1.2 11.12 63 59 107/70 0.27 1.45 
21 130/82 61 1 1.41 12.2 68 64 88166 0.38 1.87 
1 1.17 11.08 65 60 108/70 0.28 1.52 
1 1.2 11.07 64 58 98/69 0.31 1.69 
22 116/72 59 1 1.16 11.14 67 62 101/65 0.22 1.2 
1 1.13 11.08 64 60 106/69 0.24 1.31 
1 1.13 11.13 61 58 110/75 0.28 1.49 
23 102/65 61 1 1.2 11.12 67 63 102/67 0.27 1.47 
1 1.25 11.31 63 60 105/68 0.28 1.45 
1 1.32 11.57 63 60 98/66 0.35 1.78 
24 126/73 51 1 1.28 11.28 58 56 106/66 0.35 1.86 
1 1.15 11.13 58 55 111/69 0.25 1.35 
1 1.57 13.08 55 53 97/86 0.51 2.35 
25 130/74 63 1 1.36 11.21 67 61 109/66 0.44 2.34 
1 1.15 11.07 64 58 119/72 0.27 1.46 
1 1.24 11.11 62 57 162/83 0.29 1.54 
26 112/70 61 1 1.19 11.08 70 66 149/66 0.27 1.48 
1 1.15 11.08 66 62 114/67 0.26 1.4 
1 1.28 11.16 63 59 114/73 0.39 2.06 
27 124/82 58 1 1.29 11.1 65 61 114/78 0.35 1.88 
1 1.23 11.09 63 60 120/50 0.34 1.82 
1 1.19 11.08 63 60 120/78 0.27 1.47 
28 124/82 57 1 1.27 11.12 65 61 113/73 0.35 1.88 
1 1.23 11.09 63 60 118/49 0.34 1.82 
1 1.18 11.08 63 60 120/78 0.27 1.47 
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Exercise Performance Data 
Time to Fatigue: 
Pre 11 :33 
Mid 10:50 
Post 45:00:00 
Distance to • 
Fatigue: 
Pre 2.06 
Mid 1.44 
Post 9 
Kcal/hr Expended: 
Pre 9.84 
Mid 6.22 
Post 17.44 
Cardiovascular Performance Data 
MAP Resting BP Resting HR 
Pre 97.7 141176 77 
Mid 112 130/76 89 
Post 95.7 106/75 82 
Avg HR: Peak HR: 
Pre 96 Pre 107 
Mid 95 Mid 103 
Post 84 Post 102 
Upper Limb Function Data 
QIF 
? Pre Mid Post 
1 1 2 4 
2 3 0 4 
3 1 1 1 
4 3 4 2 
5 2 4 4 
6 4 4 4 
AVG 2.333333 2.5 3.166667 
STD 1.21106 1.760682 1.32916 
SUM 14 15 19 
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CUE 
? Pre Mid Post 
1a 7 7 7 
1b 7 7 7 
2a 7 7 7 
2b 7 7 7 
3a 2 5 3 
3b 2 5 3 
4 6 5 3 
Sa 7 7 7 
5b 7 7 7 
6a 6 7 6 
6b 6 7 6 
7a 7 7 7 
7b 7 7 7 
8a 6 7 6 
8b 6 7 6 
9 7 7 7 
10a 7 7 7 
10b 7 7 7 
11a 7 7 7 
11b 7 7 7 
12a 6 5 5 
12b 6 4 5 
13a 2 4 3 
13b 2 3 2 
14a 4 6 5 
14b 2 6 4 
15a 3 5 4 
15b 2 4 3 
16a 2 6 1 
16b 2 4 1 
17a 4 6 4 
17b 2 6 3 
AVG 5.0625 6.03125 5.125 
STO 2.16925 1.230903 1.995964 
SUM 162 193 164 
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Training Resting Resting Peak Avg 
Data 3 BP HR Resistance Distance Time HR HR BP Post Cal Cal/hr 
Pre 141/76 77 1 8.84 45 109 94 126/85 3.14 4.19 
1 129/72 82 1.98 8.06 45 104 91 131/91 5.67 7.56 
2 136/79 86 3.1 7.84 45 101 90 129/75 8.66 11.55 
3 128/74 75 4.08 2.06 11.33 107 96 103/82 2.22 9.84 
4 138/82 67 4.08 1.4 10.14 100 93 119/62 1.28 7.51 
4.08 1.57 11.22 99 88 118/88 2.~ 11.58 
4.08 3.78 27.23 136/71 5.39 11.8 
5 135/65 89 4.08 1.8 13.19 110 -99 111/70 2.6 11.9 
4.08 1.4 11.16 138/69 1.2 6.3 
4.08 1.2 10.1 94 80 146/74 1 5.7 
6 133/70 76 4.08 1.82 12.09 109 93 118/54 2.57 12.67 
4.08 1.42 10.29 97 87 120/72 1.22 6.97 
4.08 1.52 11.22 101 88 95/76 1.18 6.23 
7 132/73 81 4.08 1.44 10.38 95 88 118/78 1.61 9.06 .~ 
4.08 1.38 10.37 97 85 118/76 0.89 5.04 
4.08 1.29 10.1 91 80 124/78 0.57 3.37 
8 129/78 73 4.08 1.69 10.27 105 91 126/75 2.04 11.7 
4.08 1.28 10.13 97 84 119/81 0.6 3.55 
4.08 1.41 10.2 92 84 118/63 1.19 6.88 
9 142/74 77 4.08 3.03 20.26 97 89 123/77 4.35 4.42 
4.08 3.03 23.51 98 86 121/74 12.76 11.12 
10 143/79 71 4.08 3.09 18.4 113 99 104/78 4.43 14.25 I 
4.08 1.43 10.27 109 87 139/73 1.34 7.72 
11 143/77 76 4.08 1.36 10.21 99 92 122/75 1.2 6.99 
4.08 1.42 10.18 100 87 114/78 1.56 9.08 
4.08 2.63 18.56 97 87 122/71 3.44 10.89 
12 143/80 88 4.08 1.4 10.22 102 92 137/71 1.2 6.93 
4.08 3.2 17.11 130 102 126/72 4.63 16.17 
4.08 1.38 10.12 93 86 126/78 1.13 6.63 
13 123/72 94 4.08 2.12 15.25 105 96 126/81 2.61 10.14 
4.08 2.51 18.18 99 90 137/82 3.07 10.08 
14 130/79 85 4.08 1.44 10.29 142/85 1.41 8.07 
4.08 1.47 11.15 100 84 147/93 1.11 5.95 
4.08 2.08 15.18 92 80 134/82 2.13 8.34 
Mid 130/76 89 4.08 1.44 10.5 103 95 132/80 1.12 6.22 
4.08 1.28 10.54 92 86 132/83 0,28 1.53 
4.08 1.21 10.11 93 86 113/64 0,36 2.11 
16 134/69 80 4.08 1.46 11.18 103 96 124/75 1.1 5.86 
4.08 1.38 10.28 99 91 122/71 1.03 5.92 
4.08 1.46 10.55 99 88 156/106 1.2 6.6 
17 154/70 81 4.08 4.15 22.41 109 98 119/71 6.02 15.92 
4.08 1.43 11.05 96 89 116/87 0.62 3.37 
18 130/76 87 4.08 1.3 10.27 100 90 114/70 0.55 3.14 
4.08 2.05 15.14 98 88 110/74 2.08 8.18 
4.08 1.44 10.32 100 88 115/71 1.39 7.9 
19 133/77 92 4.08 6.84 45 118 99 146/98 9.9 13.21 
20 138/78 81 4.08 6.96 45 103 90 138/86 10.07 13.43 
100 
21 135/71 84 5.06 2.53 16.15 111 99 126/77 4.47 16.49 
5.06 4.44 29.29 109 91 119/75 7.74 15.75 
22 136/72 82 5.06 6.66 40.34 103 94 127/73 12.01 17.76 
23 142/90 77 5.06 8.62 45 122 96 138/85 15.51 20.68 
24 126/74 76 5.06 7.83 45 103 90 117/88 14.07 18.75 
25 98/81 84 6.04 8.66 45 112 94 125/82 18.54 24.72 
26 132/98 85 6.04 9.73 45 104 87 117/71 20.94 
27 138/62 95 7.02 5.05 29.13 116 99 118/62 12.~~1 25.7 
28 135/84 86 7.02 7.44 45 114 104 126/75 18.28 24.38 
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Exercise Performance Data 
Time to Fatigue: 
Pre 24:04:00 
Mid 45:00:00 
Post 45:00:00 
Distance to 
Fatigue: 
Pre 6 
Mid 12 
Post 10.7 
Kcal/hr Expended: 
Pre 5.4 
Mid 5.7 
Post 5.1 
Cardiovascular Performance Data 
MAP Resting BP Resting HR 
Pre 86.3 111174 70 
Mid 133 165/69 73 
Post 79.3 96/71 78 
Avg HR: Peak HR: 
Pre 84 Pre 96 
Mid 90 Mid 94 
Post 80 Post 85 
Upper Limb Function Data 
QIF 
? Pre Mid Post 
1 4 0 4 
2 3 3 3 
3 4 0 4 
4 4 0 4 
5 3 3 4 
6 4 0 4 
AVG 3.666667 1 3.833333 
STD 0.516398 1.549193 0.408248 
SUM 22 7 23 
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CUE 
? Pre Mid Post 
1a 4 5 6 
1b 4 4 6 
2a 4 4 6 
2b 4 4 6 
3a 5 6 7 
3b 5 6 7 
4 3 2 3 
Sa 6 6 7 
5b 6 6 7 
6a 4 4 4 
6b 4 4 4 
7a 5 6 7 
7b 5 6 7 
8a 3 3 3 
8b 3 3 3 
9 6 3 6 
10a 3 3 6 
10b 3 3 6 
11a 4 6 7 
11b 4 6 7 
12a 4 6 6 
12b 4 6 6 
13a 3 2 5 
13b 4 3 6 
14a 4 3 5 
14b 4 3 6 
15a 3 3 5 
15b 4 4 6 
16a 2 2 2 
16b 2 3 3 
17a 6 6 6 
17b 6 7 7 
AVG 4.09375 4.3125 5.5625 
STDEV 1.117583 1.533233985 1.457738 
SUM 131 138 178 
104 
105 
Training Resting Resting Peak Avg BP 
Data 4 BP HR Resistance Distance Time HR HR Post Cal Cal/hr 
Pre 111/74 70 1 6 24.04 96 84 116/81 2.2 5.4 
1 60 1 6.07 26.21 88 71 120/82 2.2 5.2 
1 19.39 99 114/78 
2 94/62 94 1 10.36 45 87 75 
3 124/73 85 1 10 45 80 68 98/70 3.6 4.8 
4 111/78 79 1.98 10.04 45 82 108/83 7.1 
" 
9.5 
5 102/70 82 1.98 10.32 45 107/86 7.3 9.7 
6 111/83 85 1.98 10.42 45 102 94 114/85 7.4 9.8 
7 114/82 87 2.98 9.98 45 101 95 112/74 10.6 14.1 
8 116/82 87 2.96 10.3 45 102 94 106/68 10.9 14.6 
9 99/67 88 2.96 10.74 45 72 66 128/66 11.4 15.2 
10 101/67 84 3.94 10.43 45 100 89 105/71 14.7 19.6 
11 102/69 81 3.94 10.45 45 100/68 14.7 19.6 
12 110/68 83 4.92 7.9 45 101 89 99/66 13.8 18.4 
13 113/69 91 4.92 8.18 45 ,106 97 90/62 14.4 19.2 
14 108/70 90 4.92 7.4 45 115 101 94/62 13 17.3 
15 125/77 81 5.62 8.9 45 109 65 91/66 17.8 23.8 
16 105/69 93 5.62 11.47 45 112 70 103/69 25 30.7 
Mid 165/69 73 1 12 45 94 90 122/78 4.3 5.7 
18 121/71 90 6.04 5.1 27.3 90 87 94/61 10.9 23.8 
6.04 3.11 19.3 90 87 97/64 7.7 23.8 
19 111/74 78 6.04 8.06 45 87 61 98/66 17.4 23.2 
20 99/67 88 6.04 8.54 45 102 89 83/67 18.4 24.5 
21 94/72 95 6.6 3.6 25.26 93 81 97/61 8.4 21.5 
6.6 4.51 21.34 109 87 106/70 8.3 22.3 
22 106/66 87 6.6 7.09 45 103 99 83/67 16.6 22.2 
23 99/70 83 6.6 7.03 45 153 131 81/71 16.6 22.1 
24 83/73 86 7.16 3.7 24.15 98/62 8.9 24.1 
7.16 2.1 11.07 101/65 25.2 
25 112/72 89 7.16 3.3 24.26 94/64 7.8 21 
7.16 3.16 22.34 102/69 7.9 21.4 
26 100/73 81 7.16 3.3 22.19 89 74 101/72 7.9 21.1 
7.16 2.99 20.25 86/63 7.2 21.5 
27 111/66 90 6.6 3 19.5 154/57 6.4 20.3 
6.6 2.98 20.1 96/64 6.3 19.1 
28 95/66 70 6.6 3.5 22.14 92/60 7.7 20 
6.6 3.4 21.03 87/58 7.2 19.5 
29 95/66 75 7.02 4.4 26.05 99/66 10.2 22.5 
7.02 4.67 19.55 98/69 10.3 21.4 
30 102/68 91 7.02 3.5 25.23 102 96 82/56 8 6.3 
7.02 2.87 20 90/57 20.6 20.1 
31 96/74 90 7.16 2.3 19.28 90 86 92/56 4.9 19 
7.16 2.1 14.18 114/54 4.2 17.8 
32 98/72 80 7.16 3 18.49 94 89 95/70 7 21.2 
7.16 1.6 9.32 100/60 2.6 15 
7.16 1.7 10.29 98/68 3.1 16.3 
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Participant 5 Data 
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Exercise Performance Data 
Time to Fatigue: 
Pre 11:10 
Mid 11 :08 
Post 11 :08 
Distance to 
Fatigue: 
Pre 0.83 
Mid 0.64 
Post 0.72 
Kcal/hr Expended: 
Pre 0.5 
Mid 0.5 
Post 0.5 
Cardiovascular Performance Data 
MAP Resting BP Resting HR 
Pre 80 102/69 69 
Mid 80.7 100/71 62 
Post 76 98/65 68 
Avg HR: Peak HR: 
Pre 80 Pre 89 
Mid 86 Mid 90 
Post 92 Post 97 
Upper Limb Function Data 
QIF 
? Pre Mid Post 
1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
5 0 0 0 
6 0 0 0 
AVG 0 0 0 
STD 0 0 0 
SUM 0 0 0 
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CUE 
? Pre Mid Post 
1a 1 1 1 
1b 3 2 2 
2a 1 1 1 
2b 1 1 1 
3a 1 1 1 
3b 1 1 1 
4 1 1 1 
5a 1 1 1 
5b 4 4 3 
6a 1 1 1 
6b 1 1 1 
7a 1 1 1 
7b 4 4 3 
8a 1 1 1 
8b 1 1 1 
9 1 1 1 
10a 1 1 1 
10b 1 1 1 
11a 1 1 1 
11b 1 1 2 
12a 1 1 1 
12b 1 1 1 
13a 1 1 1 
13b 1 1 1 
14a 1 1 1 
14b 1 1 1 
15a 1 1 1 
15b 1 1 1 
16a 1 1 1 
16b 1 1 1 
17a 1 1 1 
17b 2 1 2 
AVG 1.28125 1.21875 1.21875 
STDEV 0.812578 0.750672 0.552669 
SUM 41 39 39 
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Training Resting Resting Peak Avg BP 
Data 5 BP HR Resistance Distance Time HR HR Post Cal Cal/hr 
Pre 102/69 69 1 0.83 11.1 89 80 90/59 0 0 
1 102/69 69 1 0.8 11.08 107 95 103/67 0.2 0.8 
1 0.9 11.1 98 85 121/66 0.2 0.9 
1 0.8 11.08 105 83 0.1 0.3 
2 90/62 56 1 1 11.2 89 83 90/59 0 0 
1 1.1 11.09 80 79 114/74 0 
" 
0.1 
1 0.8 11.08 100/70 0 0.1 
3 86/69 69 1 0.83 11.1 e. 86/64 0.1 0.5 
1 0.9 11.1 111/74 0.1 0.6 
1 0.9 11.08 114/78 0.1 0.6 
4 78/54 73 1 0.9 11.08 93 90 94/68 0.1 0.8 
1 0.9 11.08 94 86 108/72 0.1 0.8 
1 0.9 11.08 91 87 107/66 0.1 0.6 
5 102/69 66 1 0.8 11.08 96 91 100/67 0.1 0.5 
1 0.8 11.08 ' 94 87 107/66 0.1 0.6 
1 0.9 11.09 95 89 94/66 0.1 0.6 
6 94/65 61 1 0.9 11.2 88 80 102/66 0.1 0.8 
1 0.9 11.08 88 82 96/62 0.1 0.8 
1 0.9 11.08 85 75 102/67 0.1 0.9 
7 1 0.7 11.08 80 74 101/65 0.1 0.4 
1 0.8 11.08 84 78 92/67 0.1 0.4 
1 0.8 11.08 88 82 94/62 0.1 0.5 
8 77/63 60 1 0.81 11.08 87 79 95/66 0.1 0.6 
1 0.8 11.08 83 78 97/63 0.1 0.6 
1 0.8 11.09 84 77 95/66 0.1 0.6 
9 101/70 65 1 0.7 11.08 96 90 109/71 0.1 0.3 
1 0.8 11.08 95 87 100/66 0.1 0.6 
1 0.84 11.08 98 84 98/69 0.1 0.7 
10 96/68 64 1 0.8 11.02 93 79 104/66 0.1 0.5 
1 0.79 11.02 88 76 111/70 0.1 0.5 
1 0.9 11.02 93 73 125/70 0.1 0.8 
11 83/59 56 1 0.72 11.08 88 76 87/64 0.1 0.5 
1 0.83 11.08 93 72 110/63 0.1 0.7 
1 0.74 11.08 89 76 102/67 0.1 0.6 
12 95/65 60 1 0.63 11.02 85 82 86/55 0.1 0.3 
1 0.7 11.08 90 80 88/56 0.1 0.3 
1 0.8 11.08 93 80 82/54 0.1 0.5 
13 102/75 61 1 0.7 11.08 89 82 98/63 0.1 0.5 
1 0.82 11.08 85 75 83/66 0.1 0.6 
1 0.8 11.08 86 79 98/66 0.1 0.7 
14 90/65 63 1 0.67 11.08 83 79 94/56 0.1 0.4 
1 0.69 11.08 85 78 94/62 0.1 0.4 
1 0.74 11.08 88 77 88/57 0.1 0.6 
15 102/68 59 1 0.6 11.08 93 88 108/66 0.1 0.4 
1 0.69 11.08 89 81 72/56 0.1 0.4 
1 0.67 11.08 89 81 122/74 0.1 0.5 
16 86/69 58 1 0.71 11.08 90 82 101/66 0.1 0.5 
111 
1 0.69 11.09 90 81 121/73 0.1 0.5 
1 0.7 11.08 95 83 118/74 0.1 0.5 
17 112/80 57 1 0.59 11.08 93 88 102/66 0 0.3 
1 0.61 11.08 94 90 112/70 0.1 0.4 
1 0.6 11.08 88 82 118/77 0 0.3 
Mid 100/71 62 1 0.64 11.08 90 86 114/69 0.1 0.5 
18 102/70 62 1 0.69 11.08 96 86 107/66 0.1 0.5 
1 0.74 11.08 104 88 112/56 0.1 ~;r 0.5 
1 0.72 11.08 94 82 121/70 0.1 0.6 
19 106/79 59 1 0.55 11.08 99 91 121/65 0.1 0.4 
1 0.65 11.08 106 92 118/74 0.1 0.5 
1 0.7 11.08 114 95 128/75 0.1 0.4 
20 82/59 66 1 0.7 11.08 102 95 82/66 0.1 0.4 
1 0.61 11.08 100 94 108/75 0.1 0.4 
1 0.56 11.08 90 81 109/70 0.1 0.4 
21 101/70 60 1 0.6 11.08 106 93 114/71 0.1 0.4 
1 0.65 11.08 99 84 113/75 0.1 0.3 
1 0.71 11.08 85 77 129/86 0.1 0.4 
22 91/64 69 1 0.6 11.09 111 95 114/70 0.1 0.4 
1 0.71 11.08 107 89 119/69 0.1 0.5 
1 0.75 11.09 108 88 124/76 0.1 0.5 
23 112/78 61 1 0.62 11.08 96 87 93/61 0.1 0.4 
1 0.73 11.08 94 79 110/73 0.1 0.5 
1 0.78 11.08 98 80 110/73 0.1 0.6 
24 104/75 72 1 0.73 11.08 107 95 117/77 0.1 0.6 
1 0.76 11.08 111 90 126/82 0.1 0.4 
1 0.83 11.08 110 89 98/80 0.1 0.6 
25 105/74 68 1 0.7 11.11 112 95 122/71 0.1 0.5 
1 0.65 11.08 100 89 130/70 0 0.3 
1 0.66 11.08 94 87 129/82 0 0.2 
26 86/64 67 1 0.77 11.11 105 94 112/66 0.1 0.7 
1 0.74 11.08 105 95 106/74 0.1 0.7 
1 0.74 11.1 108 96 120/70 0.1 0.5 
27 115/106 74 1 0.72 11.11 99 91 107/63 0.1 0.5 
1 0.67 11.08 96 86 113/74 0.1 0.5 
1 0.6 11.08 93 87 115/66 0.1 0.4 
28 74/56 66 1 0.73 11.1 106/69 0.1 0.6 
1 0.68 11.08 99 92 105/73 0.1 0.4 
1 0.75 11.08 94 88 119/73 0.1 0.4 
29 81/58 61 1 0.67 11.1 95 85 107/64 0.1 0.4 
1 0.69 11.08 94 82 76/60 0.1 0.5 
1 0.68 11.09 92 84 102/68 0.1 0.6 
30 87/66 60 1 0.71 11.12 98 87 117/64 0.1 0.4 
1 0.73 11.1 98 83 105/63 0.1 0.5 
1 0.71 11.07 98 83 106/66 0.1 0.4 
31 93/62 56 1 0.67 11.1 96 84 97/59 0.1 0.4 
1 0.68 11.08 94 82 93/58 0.1 0.5 
1 0.71 11.08 84 77 99/66 0.1 0.4 
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